Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
IWM [NYSE]
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.63%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.46%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter1.89%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y8.79%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year13.85%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range102.84 - 127.13 Perf YTD4.34%
Dividend1.63 P/FCF- EPS past 5Y- ROI- 52W High-2.12% Beta-
Dividend %1.31% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low20.99% ATR1.43
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)54.90 Volatility0.98% 1.22%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.83 Prev Close124.97
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume27.30M Price124.43
Recom- SMA200.90% SMA500.24% SMA2005.94% Volume22,591,593 Change-0.43%
May-23-15 08:19AM  What You Need To Know About This Higher Risk Stage Of The Bull Market
08:01AM  What to expect from the stock market this week
May-22-15 07:07PM  The Week Ahead: 3 Reasons to Put Stocks on Your Summer Shopping List at Forbes
05:20PM  Small Cap Volatility Hitting Historic Lows
04:12PM  Are Large Caps the Go-To Stocks Yet?
02:09PM  Janet Yellen just made one of the most surprising admissions you'll ever hear from an economist
01:34PM  And so ends the first 5 years.....
01:01PM  YELLEN: Rate hikes are coming this year
11:15AM  Big put buying in small-cap ETF
10:59AM  Heres what CEOs said about the economy this week
10:35AM  Trading Around Memorial Day Historically Bullish
09:33AM  4 Ways to Improve Your Retirement Savings
08:30AM  Consumer prices rise as expected in April
May-21-15 06:09PM  The Non-Conspiracy In 1Q GDP Adjustments
04:59PM  Top 10 most questionable Wall Street sayings (in honor of Lettermans retirement)
02:28PM  The Diversification Dividend
10:17AM  What Should You Do With The Current Divergence Thats In Place
07:45AM  Stock market rally lacks a certain style
02:25AM  What Is The Grand-Daddy Of Divergences Telling Us Now?
May-20-15 05:05PM  NASDAQ lags typical pre-election by over 10% worse than S&P and DJIA
01:53PM  Investors All Hold The Same Opinion, And Thats Not Good
12:25PM  2015 And Historical Bear Market Triggers
May-19-15 06:04PM  Dow theory asks, wheres the confirmation?
03:15PM  The US is now the most hated equity market in the world
02:02PM  Breakouts Or Fakeouts?
11:45AM  Tactical Asset Allocation: Beware of Geeks Bearing Formulas
10:29AM  Your favorite Rush songand the S&P 500
09:00AM  Warren Buffett sounds like a hypocrite because he just doesnt think very highly of you
08:23AM  Top Wall Street strategist gets hate mail and fires back after discovering his critic is actually 'bad at their job'
07:20AM  The S&P 500 made a new all-time high, but....
May-18-15 05:47PM  Trading generally bullish the week before Memorial Day weekend
04:19PM  Stock Market Video Analysis 5/18/15
04:01PM  Going back to 'TINA' market: Pro
03:35PM  Smart-Beta ETFs Could Give Active Managers A Run for Their Money
02:02PM  Better Search Methods Can Improve Hiring Outcomes
01:58PM  The Priceless Art of Not Caring
01:40PM  London Stock Exchange Combines FTSE, Russell Brands
01:10PM  Trading macro events and reports (part I)
01:02PM  Move to new highs may now be tricky for stocks at MarketWatch
12:21PM  Is The Smart Money Running For Cover?
09:02AM  Are CEOs really being paid too much?
08:03AM  Is the Stock Market Due for a Correction?
07:55AM  Wall Street is on the verge of saying 'recession'
06:58AM  Famed Short Seller Jim Chanos Is Long ETFs
06:01AM  What is Your Investment Philosophy Based On?
May-16-15 09:10AM  Are The Odds Increasing For A Stock Market Correction?
08:01AM  What to expect from the stock market this week
May-15-15 04:00PM  STOCKS GO NOWHERE: Here's what you need to know
02:24PM  Alternative Thinking vs. Alternative Assets
01:43PM  Selling Premium As Small Caps Play Catch Up at Investopedia
12:52PM  Loeb's Third Point Sold $1 Billion in Alibaba Stock at Barrons.com
12:05PM  Time To Sell Junk Bonds? Maybe Not
11:46AM  ChartAdvisor for May 15 2015 at Investopedia
10:56AM  Heres what CEOs said about the economy this week
09:04AM  How Often Are Markets Normal?
May-14-15 03:36PM  This 5k loss was my best trade of the month (video)
02:50PM  With Banks At New Highs, Are Stocks Out Of The Woods?
02:20PM  A Bullish Scenario For Stocks
12:48PM  Wall Street is starting to wonder: What if everything's going to be OK?
10:23AM  Liquidity Risk: Same as it Ever Was
10:18AM  Are we still in a bull market?
08:03AM  Six Networking Lessons to Remember
May-13-15 10:06PM  Looking for clues for where the stock market is headed?
04:43PM  Active Funds Winning in 2015 So Far
01:50PM  Misleading Read on Retail Sales
01:07PM  Welcome to the everything bubble
11:21AM  The Cardinal Sin: Missing Out
May-12-15 03:01PM  Stock Indicator Suggests Big Move (Lower?) Coming
01:07PM  Why a stock market crash may once again be inevitable
11:17AM  Heres What the Bond Market Rout Is Telling Us
May-11-15 05:44PM  Suddenly, the stock market has gotten boring
05:12PM  A Look At Corporate Profit Margins
02:01PM  Portfolio Evaluation: Benchmarking for Success
12:22PM  Talk Of A Stock Market Crash How Concerned Should We Be?
12:19PM  Technical Analysis of the S&P 500
10:28AM  The Stock Market is Shrinking
08:03AM  Country Risk: A Tale of Two Models
07:27AM  What are traders chatting about this morning? Greek stocks getting slammed ...
May-10-15 10:46PM  William Faulkners advice to traders: Kill your darlings!
10:35PM  Don't look now but markets aren't going anywhere just yet
May-09-15 09:48AM  Big Change On An Important Chart
08:02AM  What to expect from the stock market this week
May-08-15 09:15PM  German Bunds Sneeze, U.S. Stocks Get a Cold at Barrons.com
07:41PM  The Week Ahead: Are These Key Markets Changing Direction? at Forbes
06:59PM  Reducing Bear Market Danger With The 4% Rule at Investor's Business Daily
05:29PM  NFL Rookies, Heres How to Play the Investing Game
04:00PM  What To Worry About, And What To Ignore, In This Equity Market
01:08PM  Heres what CEOs said about the economy this week
11:28AM  ChartAdvisor for May 8 2015 at Investopedia
10:49AM  Is it Wise to Diversify with Small-Caps? at Investopedia
07:00AM  Final Pillar Of Bull Market Showing Cracks?
May-07-15 01:47PM  3 Trends That helped Alternative Managed Futures Funds earn solid returns during 2014 and Q1 2015:
07:35AM  What are traders chatting about this morning? The technicals ...
May-06-15 08:43PM  What is that hissing sound? The air and confidence being let out of markets
01:30PM  Why record-high margin debt should make you more cautious
01:28PM  Why investor flight out of stock funds may signal a rally at MarketWatch
01:06PM  Achieving Alpha With Market Anomalies
07:53AM  Why stock buybacks can either be good or bad
07:00AM  Mid-Cap Stocks: In the Sweet Spot at Morningstar
May-05-15 09:26PM  Correction Ahead
The investment seeks to track the investment results of an index composed of small-capitalization U.S. equities. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Russell 2000 Index (the "underlying index"), which measures the performance of the small-capitalization sector of the U.S. equity market.
DHR [NYSE]
Danaher Corp.
IndexS&P 500 P/E23.99 EPS (ttm)3.61 Insider Own1.50% Shs Outstand707.53M Perf Week0.19%
Market Cap61.28B Forward P/E18.31 EPS next Y4.73 Insider Trans-5.30% Shs Float619.96M Perf Month2.27%
Income2.59B PEG2.67 EPS next Q1.04 Inst Own78.40% Short Float1.42% Perf Quarter-0.13%
Sales20.12B P/S3.05 EPS this Y-4.20% Inst Trans-0.31% Short Ratio2.57 Perf Half Y5.18%
Book/sh32.98 P/B2.63 EPS next Y10.59% ROA7.20% Target Price98.59 Perf Year11.58%
Cash/sh3.55 P/C24.40 EPS next 5Y9.00% ROE11.00% 52W Range69.93 - 90.25 Perf YTD1.21%
Dividend0.54 P/FCF21.10 EPS past 5Y17.40% ROI9.50% 52W High-4.03% Beta1.21
Dividend %0.62% Quick Ratio1.40 Sales past 5Y13.60% Gross Margin52.60% 52W Low23.85% ATR1.24
Employees71000 Current Ratio1.80 Sales Q/Q4.50% Oper. Margin17.00% RSI (14)58.31 Volatility1.12% 1.44%
OptionableYes Debt/Eq0.14 EPS Q/Q-2.50% Profit Margin12.90% Rel Volume0.86 Prev Close86.90
ShortableYes LT Debt/Eq0.13 EarningsApr 23 BMO Payout11.80% Avg Volume3.43M Price86.61
Recom1.80 SMA202.47% SMA501.86% SMA2005.78% Volume2,937,970 Change-0.33%
May-22-15Reiterated JP Morgan Overweight $80 → $94
May-18-15Reiterated UBS Buy $100 → $108
May-18-15Reiterated Argus Buy $92 → $95
Jan-28-15Reiterated Stifel Buy $95 → $100
Jan-22-15Initiated UBS Buy $100
Dec-12-14Reiterated Barclays Overweight $86 → $93
Nov-26-14Reiterated FBR Capital Outperform $95 → $100
Nov-21-14Reiterated Argus Buy $86 → $92
Nov-12-14Upgrade FBR Capital Mkt Perform → Outperform $83 → $95
Oct-17-14Reiterated Barclays Overweight $79 → $86
Oct-16-14Reiterated ISI Group Buy $88.50 → $86.50
Sep-17-14Resumed Stifel Buy $90
Apr-09-14Upgrade ISI Group Buy → Strong Buy $86
Dec-31-13Reiterated FBR Capital Mkt Perform $73 → $83
Jul-10-13Reiterated ISI Group Buy $69.50 → $73
Apr-18-13Reiterated ISI Group Buy $70 → $68
Mar-25-13Reiterated Deutsche Bank Hold $64 → $70
Mar-18-13Reiterated FBR Capital Mkt Perform $54 → $63
Jan-30-13Reiterated UBS Buy $60 → $69
Jan-30-13Reiterated Barclays Equal Weight $23 → $27
May-22-15 12:06PM  What Is the Expected Timing of the PallDanaher Transaction?
12:06PM  Danaher Intends to Split Up Next Year
11:53AM  Danaher is 'Looking Brilliant' After Pall's Big Beat at Barrons.com
May-21-15 03:57PM  Pall-Danaher Transaction: What You Should Know about Danaher
03:57PM  Pall-Danaher Transaction: An Overview of Pall
11:45AM  PALL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Pall Corporation Over the Proposed Sale of the Company to Danaher Corporation - PLL PR Newswire
11:42AM  Basics of the PallDanaher Transaction
11:41AM  The PallDanaher Spread is Trading Like a Safe Deal
May-20-15 04:19PM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-19-15 06:01PM  Yahoo Stock Dives On Feared IRS Spinoff Rule Changes at Investor's Business Daily
05:00PM  Yahoo tanks on IRS spinoff scare
12:01PM  What Makes Danaher Corp. Such a Star?
07:00AM  Ultimate Stock-Pickers Top 10 High-Conviction and New-Money Purchases at Morningstar
06:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-18-15 04:00PM  Danaher Announces Quarterly Dividend PR Newswire
May-15-15 04:11PM  PALL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pall Corporation PR Newswire
11:30AM  Danaher-NetScout Deal: Initiates Shares Exchange Offer - Analyst Blog
07:09AM  Danahers Industrial Blueprint for Business Growth at Bloomberg
05:09AM  U.S. dealmaking climbs 48 percent to highest levels since 2007
May-14-15 02:53PM  Deutsche Bank: Danaher Deal May Fail To Meet Goals
01:31PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pall Corporation of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to Danaher Corporation -- PLL PR Newswire
11:40AM  Danaher to Buy Pall for $14B; Plans to Split Itself - Analyst Blog
11:33AM  Danaher: Going to $100? at Barrons.com
08:12AM  Guilty Banks and Complaining Spoofers
08:00AM  Danaher Commences Split-Off Exchange Offer For Its Communications Business In Connection With NetScout Transaction PR Newswire
07:27AM  'Now-or-never' fear drives corporate deal boom
06:00AM  Jim Cramer: Companies Play a Big Role in Pushing Their Stocks Higher at TheStreet
12:39AM  [$$] Danaher to Split Up Businesses, Buy Pall for $13.6 Billion at The Wall Street Journal
May-13-15 07:20PM  Danaher to Buy Pall, Split Up Businesses at The Wall Street Journal
06:48PM  Danaher To Buy Pall For $13.8 Billion, Split In 2
06:48PM  Danaher Acquiring Pall, Splitting Off Industrial Biz at Investor's Business Daily
06:13PM  Listen up! Cramer calls for bold CEO action at CNBC
06:00PM  Cramer: Don't just stand there, do something!
05:59PM  McKesson, Other Top Stocks Fade After Hitting New Highs at Investor's Business Daily
04:14PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements
04:13PM  Robbins Arroyo LLP: Acquisition of Pall Corporation (PLL) by Danaher Corporation (DHR) May Not Be in Shareholders' Best Interests PR Newswire
04:09PM  Stocks Little Changed as Investors Weigh Good and Bad of Weak Retail Data at TheStreet
03:54PM  Pall Corporation -- Moody's changes outlook on Danaher to negative on Pall Corp acquisition; affirms A2, P-1 ratings at Moody's
02:56PM  Stocks Are Flat as Retail Data Disappoints, DuPont Drags at TheStreet
02:21PM  Danaher Breakup And The New Corporate Activism, With Or Without Wall Street at Forbes
02:16PM  Billionaire Rales Brothers Revamp Danaher Empire As Part Of $13.8 Billion Pall Deal at Forbes
01:21PM  4 Big Stocks Getting Big Attention -- and How to Trade Them at TheStreet
01:08PM  Danaher Holders Finally Get What Theyve Waited For: Real M&A at Bloomberg
11:48AM  Danaher Grabs Pall for $13.8B and Plans to Split Merged Company at TheStreet
11:43AM  Danaher buying Pall for about $13.56 billion at Los Angeles Times
11:39AM  Why Danaher's Purchase of Pall Means More M&A is on the Way at Barrons.com
10:56AM  Law Firm Block & Leviton LLP Investigates Pall Corporation for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Danaher Corporation PR Newswire
10:43AM  Danaher splitting into two, makes biggest ever acquisition at bizjournals.com
10:35AM  Danaher to Buy Pall for $13.8 Billion, Split Itself in Two
10:06AM  Danaher (DHR) Stock Soaring on Pall Corp. Acquisition, Split Announcements at TheStreet
10:02AM  PALL CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
09:41AM  Stocks Bounce Back Despite Flat Retail Sales at TheStreet
09:06AM  Macy's slips on miss; Delta rewards investors; Pall jumps on Danaher buyout
08:51AM  Morning Movers: Vertex Jumps on FDA Panel Decision; Danaher Buys Pall at Barrons.com
08:46AM  Stock Futures Trim Gains After Retail Sales in April Are Flat at TheStreet
08:35AM  Danaher To Acquire Pall, Intends To Split Into 2 Companies
08:04AM  Retail sales disappoint; Facebook's news hosting; Tweet your pizza order
07:47AM  Danaher to buy Pall Corp for $13.8 bln
07:35AM  Danaher to Buy Pall for $13.8 Billion, Split Into Two Companies
07:31AM  Danaher Announces Intention to Separate Into Two Independent, Publicly Traded Companies PR Newswire
07:30AM  Danaher To Acquire Pall Corporation For $127.20 Per Share, Or $13.8 Billion PR Newswire
May-12-15 06:11PM  Cramer: Don't worry about rate swings...Here's why at CNBC
11:43AM  Pall Climbs After Report Filtration Maker May Be Bought at Bloomberg
11:18AM  Stocks Stumble In Rising Trade; Pall Soars, NewLink Dives at Investor's Business Daily
10:51AM  It's Not Just the AOL & Verizon Deal That's Moving the M&A Needle at Barrons.com
09:35AM  Pall Corp. Stock Soars On Reports Of Imminent Sale at Investor's Business Daily
09:21AM  Morning Movers: Pall Jumps on Possible Sale; Gaps Falls on Downgrade at Barrons.com
09:09AM  Bond Slide Hits Stock Futures; AOL, Pall Surge On Buyout News at Investor's Business Daily
May-11-15 08:33PM  Pall Corp in final stages for sale of filter maker -WSJ
07:23PM  Pall nears sale that sets its value above $10B: DJ at CNBC
07:47AM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S
May-05-15 05:23PM  Danaher To Present At Electrical Products Group Conference at noodls
04:00PM  Danaher To Present At Electrical Products Group Conference PR Newswire
May-04-15 03:14PM  B&G Foods Announces Closing of Public Offering of Common Stock at noodls
Apr-29-15 09:51AM  B&G Foods Announces Pricing of Public Offering of Common Stock at noodls
Apr-28-15 04:42PM  B&G Foods Announces Public Offering of Common Stock at noodls
03:38PM  3M (MMM) Earnings Analysis: By the Numbers
01:04PM  DANAHER CORP /DE/ Financials
09:44AM  Oil & Gas Stock Roundup: Weatherford Posts Q1 Loss, to Cut 10,000 Jobs - Analyst Blog
Apr-27-15 10:29AM  Roper Technologies Beats Q1 Earnings, Misses Revenues - Analyst Blog
Apr-25-15 08:09PM  10-Q for Danaher Corp. at Company Spotlight
Apr-24-15 05:02PM  Can Roper Industries (ROP) Keep the Earnings Streak Alive? - Analyst Blog
Apr-23-15 04:45PM  B&G Foods Reports Financial Results for First Quarter 2015 at noodls
04:10PM  Danaher (DHR) Meets Q1 Earnings, Revenues Top Estimate - Analyst Blog
04:01PM  Danaher (DHR) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
10:11AM  Danaher Cuts Earnings Outlook at The Wall Street Journal
09:18AM  5 Big Stock Charts to Trade for Gains at TheStreet
08:00AM  Danaher Corp Earnings Call scheduled for 8:00 am ET today
07:54AM  Danaher Posts In-Line Q1 Earnings, Revenues Beat - Tale of the Tape
07:07AM  Q1 2015 Danaher Corp Earnings Release - 06:00 am ET
06:43AM  NetScout Receives U.S. Department of Justice Clearance For Acquisition of Danaher Communications Business at noodls
06:43AM  Danaher Reports Record First Quarter 2015 Results at noodls
06:09AM  Danaher meets 1Q profit forecasts
06:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
06:00AM  NetScout Systems Receives Hart-Scott-Rodino Clearance for Acquisition and Announces Date for Special Stockholders Meeting Business Wire
06:00AM  NetScout Receives U.S. Department of Justice Clearance For Acquisition of Danaher Communications Business PR Newswire
06:00AM  Danaher Reports Record First Quarter 2015 Results PR Newswire
Apr-21-15 11:39PM  Manning & Napier's Top 5 Stock Selections of Q1
03:50PM  Is Danaher (DHR) Poised to Beat Earnings This Season? - Analyst Blog
Apr-10-15 03:00PM  Roper's Acquisitions to Drive Growth, Debt Remains a Drag - Analyst Blog
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; hardware and software solutions to deploy, manage, and secure communication network technologies and services; and tools, toolboxes, and automotive maintenance equipment. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company's Life Sciences & Diagnostics segment provides various research tools for scientists to study cells and cell components; and various analytical instruments, reagents, consumables, software, and services for hospitals, physician's offices, reference laboratories, and other critical care settings. Its Dental segment provides various dental consumables, equipment, and services for the diagnosis, treatment, and prevention of disease and ailments of the teeth, gums, and supporting bone. The company's Industrial Technologies segment offers equipment, consumables, and software for consumer and industrial products; and mechanical and electromechanical motion control solutions for the automation market. It also provides sensors and control instruments to manufacturing markets and electric utility industry; energetic material systems to systems integrators and prime contractors; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Graham Jonathan PSenior VP & GCMay 19Option Exercise50.8237,7321,917,52264,838May 20 05:22 PM
Graham Jonathan PSenior VP & GCMay 19Sale86.8930,2322,626,85034,606May 20 05:22 PM
Graham Jonathan PSenior VP & GCMay 15Option Exercise37.1349,7551,847,37168,026May 18 05:17 PM
Graham Jonathan PSenior VP & GCMay 15Sale87.0049,7554,328,88927,106May 18 05:17 PM
Graham Jonathan PSenior VP & GCMay 14Option Exercise32.69135,8654,441,851162,971May 18 05:17 PM
Graham Jonathan PSenior VP & GCMay 14Sale88.00135,86511,956,12027,106May 18 05:17 PM
DANIEL WILLIAM KEVPApr 24Option Exercise34.7058,4002,026,588142,950Apr 27 05:20 PM
COMAS DANIEL LEVP & CFOApr 24Option Exercise25.8525,000646,250124,798Apr 27 05:20 PM
Joyce Thomas Patrick JRPresident and CEOApr 24Option Exercise37.0725,300937,871159,768Apr 27 05:20 PM
COMAS DANIEL LEVP & CFOApr 24Sale83.5025,0002,087,38699,798Apr 27 05:20 PM
Joyce Thomas Patrick JRPresident and CEOApr 24Sale83.8143,9453,683,076115,823Apr 27 05:20 PM
DANIEL WILLIAM KEVPApr 24Sale83.3358,4004,866,313112,950Apr 27 05:20 PM
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale87.794,179366,86216,662Feb 27 05:30 PM
Graham Jonathan PSenior VP & GCFeb 24Sale86.779,961864,33627,106Feb 25 08:04 PM
Raskas DanielSVP-Corporate DevelopmentFeb 20Option Exercise30.7356,0001,720,88081,808Feb 23 05:07 PM
Raskas DanielSVP-Corporate DevelopmentFeb 20Sale87.0356,0004,873,90425,808Feb 23 05:07 PM
EHRLICH DONALD JDirectorFeb 03Option Exercise28.168,000225,28095,635Feb 04 05:05 PM
EHRLICH DONALD JDirectorFeb 03Sale84.828,000678,56087,635Feb 04 05:05 PM
LICO JAMES AExecutive Vice PresidentFeb 02Option Exercise30.7398,0003,011,540246,606Feb 03 05:47 PM
LICO JAMES AExecutive Vice PresidentFeb 02Sale82.6498,0008,099,070148,606Feb 03 05:47 PM
COMAS DANIEL LEVP & CFOJan 28Option Exercise25.8575,0001,938,750193,695Jan 29 05:46 PM
COMAS DANIEL LEVP & CFOJan 28Sale84.5975,0006,344,503118,695Jan 29 05:46 PM
DITKOFF JAMES HSenior VP-Finance & TaxNov 20Sale82.353,606296,954172,948Nov 21 04:26 PM
LICO JAMES AExecutive Vice PresidentOct 31Sale80.3925,2382,028,885103,451Nov 04 05:58 PM
Graham Jonathan PSenior VP & GCOct 30Option Exercise37.0720,000741,40063,969Nov 03 05:18 PM
Graham Jonathan PSenior VP & GCOct 30Sale79.2720,0001,585,50043,969Nov 03 05:18 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 20Option Exercise30.7340,0001,229,20065,808Oct 21 05:05 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 20Sale74.6540,0002,986,12025,808Oct 21 05:05 PM
COMAS DANIEL LEVP & CFOOct 17Option Exercise25.8550,0001,292,500168,695Oct 21 05:04 PM
COMAS DANIEL LEVP & CFOOct 17Sale75.1050,0003,755,075118,695Oct 21 05:04 PM
LOHR WALTER GDirectorSep 04Option Exercise26.188,000209,440460,635Sep 04 06:31 PM
King WilliamSenior Vice PresidentAug 01Sale73.743,545261,40824,329Aug 04 07:38 AM
SCHWIETERS JOHN TDirectorMay 28Option Exercise26.188,000209,44019,752May 30 07:29 AM
SCHWIETERS JOHN TDirectorMay 28Sale78.738,000629,84011,752May 30 07:29 AM
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E25.77 EPS (ttm)1.27 Insider Own0.10% Shs Outstand517.75M Perf Week1.21%
Market Cap16.95B Forward P/E19.31 EPS next Y1.70 Insider Trans-9.06% Shs Float510.47M Perf Month2.73%
Income701.00M PEG5.15 EPS next Q0.23 Inst Own83.80% Short Float1.85% Perf Quarter-7.63%
Sales7.39B P/S2.29 EPS this Y70.70% Inst Trans-2.13% Short Ratio2.66 Perf Half Y-3.50%
Book/sh9.58 P/B3.42 EPS next Y49.47% ROA12.10% Target Price36.58 Perf Year10.61%
Cash/sh2.24 P/C14.63 EPS next 5Y5.00% ROE29.10% 52W Range29.37 - 36.73 Perf YTD-8.05%
Dividend1.16 P/FCF332.27 EPS past 5Y28.50% ROI10.60% 52W High-10.90% Beta1.43
Dividend %3.54% Quick Ratio2.40 Sales past 5Y7.90% Gross Margin21.70% 52W Low11.45% ATR0.50
Employees12800 Current Ratio3.10 Sales Q/Q-0.90% Oper. Margin17.50% RSI (14)55.83 Volatility1.38% 1.58%
OptionableYes Debt/Eq1.08 EPS Q/Q-41.40% Profit Margin22.90% Rel Volume1.10 Prev Close32.58
ShortableYes LT Debt/Eq1.08 EarningsMay 01 BMO Payout34.70% Avg Volume3.54M Price32.73
Recom2.20 SMA202.03% SMA500.64% SMA200-2.58% Volume3,912,648 Change0.46%
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Jan-29-13Reiterated Argus Buy $33 → $36
Jan-28-13Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $31
Jan-16-13Reiterated BMO Capital Markets Market Perform $28.50 → $33
Jul-17-12Downgrade BMO Capital Markets Market Perform → Underperform
Jul-06-12Downgrade DA Davidson Buy → Neutral $27 → $23
Mar-05-12Upgrade BMO Capital Markets Underperform → Market Perform $33 → $36
Feb-06-12Reiterated BMO Capital Markets Underperform $16 → $20
Oct-31-11Upgrade Deutsche Bank Sell → Hold $19 → $19
Aug-12-11Upgrade RBC Capital Mkts Underperform → Sector Perform $18 → $18
Aug-10-11Upgrade UBS Sell → Neutral
Aug-05-11Upgrade DA Davidson Neutral → Buy $22 → $22
Aug-01-11Reiterated Barclays Capital Overweight $33 → $31
Jun-06-11Upgrade DA Davidson Underperform → Neutral
Feb-07-11Reiterated Deutsche Bank Hold $20 → $24
May-22-15 05:26PM  Weyerhaeuser Company Declares Dividend on Common Shares PR Newswire
May-20-15 03:14PM  Gov't agency 'aware of issues' in GDP data
May-15-15 06:00AM  The 10 stocks likely to drop this summer: Goldman at CNBC
May-12-15 09:21AM  Cramer's Mad Dash: RAX & RDS.a
May-09-15 12:01AM  Can Third Avenue Get Back On Track? at Barrons.com
May-03-15 08:13PM  10-Q for Weyerhaeuser Co. at Company Spotlight
May-01-15 04:50PM  Weyerhaeuser (WY) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
10:07AM  Weyerhaeuser Misses Q1 Earnings and Revenues, Down Y/Y - Analyst Blog
08:15AM  Polcari: The Kiss Of Death, Weak GDP and the Iran Effect at Investor's Business Daily
07:53AM  Early movers: NWL, MCO, VFC, CVS, LNKD & more at CNBC
07:37AM  Weyerhaeuser's Profit Falls at The Wall Street Journal
07:07AM  Q1 2015 Weyerhaeuser Co Earnings Release - Before Market Open
06:03AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:03AM  Weyerhaeuser misses Street 1Q forecasts
04:22AM  Weyerhaeuser (WY) Q1 Earnings and Revenues Lag Estimates - Tale of the Tape
03:05AM  Weyerhaeuser Reports First Quarter Results PR Newswire
Apr-30-15 07:12PM  Stocks entering May with low expectations at CNBC
10:15AM  Moving Average Crossover Alert: Weyerhaeuser (WY) - Tale of the Tape
Apr-29-15 05:58PM  Will Weyerhaeuser (WY) Miss Q1 Earnings on Market Woes? - Analyst Blog
Apr-14-15 01:44PM  Weyerhaeuser Company -- Moody's upgrades Weyerhaeuser to Baa2 at Moody's
Apr-03-15 07:00PM  Weyerhaeuser to Release First Quarter Results on May 1 at noodls
06:35PM  Weyerhaeuser to Release First Quarter Results on May 1 PR Newswire
Mar-19-15 11:00AM  Watch Out Below For Falling Lumber Prices at Investopedia
Mar-15-15 10:44AM  5 Trade Ideas for Monday: Cigna, Hain Celestial, Old Dominion Freight Line, PerkinElmer & Weyerhaeuser
Mar-12-15 11:55AM  Work underway on Weyerhaeuser's glassy new Seattle headquarters at bizjournals.com
Feb-20-15 05:00PM  Simons, Bedient to Represent Weyerhaeuser at Upcoming Investor Conferences PR Newswire
01:04PM  WEYERHAEUSER CO Financials
Feb-17-15 10:28AM  Weyerhaeuser Gains on Housing Market Revival, Runs Risks - Analyst Blog
Feb-15-15 07:07PM  10-K for Weyerhaeuser Co. at Company Spotlight
Feb-13-15 04:19PM  Weyerhaeuser Company Declares Dividend on Common Shares at noodls
04:15PM  Weyerhaeuser Company Declares Dividend on Common Shares PR Newswire
Feb-11-15 07:00AM  Weyerhaeuser Company (WY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
Feb-06-15 03:20PM  How a West Coast port closure would hurt the economy at MarketWatch
Feb-02-15 01:11PM  The Reincarnation of Bell Labs at Fortune
10:10AM  Company News for February 02, 2015 - Corporate Summary
Jan-30-15 04:25PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St EDGAR Online
04:10PM  Weyerhaeuser Announces Election of David Bozeman to Board of Directors PR Newswire
02:46PM  Weyerhaeuser (WY) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
12:40PM  Weyerhaeuser Q4 Earnings and Revenues Miss Estimates - Analyst Blog Zacks
07:57AM  Early movers: YHOO, FL, TYC, XRX, TSN & more at CNBC
07:07AM  Q4 2014 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
05:10AM  Weyerhaeuser misses Street 4Q forecasts AP
04:54AM  Weyerhaeuser (WY) Q4 Earnings and Revenues Lag Estimates - Tale of the Tape Zacks
03:05AM  Weyerhaeuser Reports Fourth Quarter, Full Year Results PR Newswire
Jan-29-15 02:46PM  What to Expect When Weyerhaeuser (WY) Reports Fourth-Quarter Earnings Tomorrow at TheStreet
08:58AM  Why Earnings Season Could Be Great for Weyerhaeuser (WY) - Tale of the Tape Zacks
Jan-28-15 08:04PM  Farallon Capital sells stake in Weyerhaeuser Co. Market Realist
02:00PM  Can Weyerhaeuser Beat Q4 Earnings on Housing Recovery? - Analyst Blog Zacks
06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at American City Business Journals
Jan-20-15 12:45PM  ETF Securities Branches out From Commodities ETFs ETF Trends
11:10AM  Will United Rentals (URI) Miss Earnings Estimates in Q4? - Analyst Blog Zacks
Jan-13-15 06:29PM  Washington's employers may soon face a legion of allied unions at American City Business Journals
01:22PM  Weyerhaeuser Announces Tax Treatment of 2014 Distributions PR Newswire
Jan-08-15 06:15PM  Weyerhauser to cut jobs in response to port slowdown at American City Business Journals
Dec-29-14 01:01PM  Weyerhaeuser to release fourth quarter earnings on Jan. 30 PR Newswire
Dec-22-14 04:56PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
Dec-21-14 08:30AM  5 Trade Ideas for Monday: Domino's, Conagra, Schlumberger, AmerisourceBergen & Weyerhaeuser Yahoo Finance Blogs
Dec-19-14 11:39AM  Farallon Capital starts new position in International Game Technology Market Realist
Nov-20-14 02:44PM  Wynn Resorts Probed on Money-Laundering Controls The Wall Street Journal
Nov-14-14 04:50PM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and EDGAR Online
04:30PM  Weyerhaeuser Announces Leadership Changes for Cellulose Fibers, Wood Products PR Newswire
Nov-12-14 04:59PM  Get Ideas For Stock Buys, Sells In Mutual Fund Monthly Reports Investor's Business Daily
Nov-04-14 06:38PM  Boise Cascade Building Profit Ahead Of New-Home Cycle at Investor's Business Daily
Nov-03-14 07:08PM  10-Q for Weyerhaeuser Co. Company Spotlight
12:07PM  3 Materials & Construction Stocks Moving The Industry Upward at TheStreet
Oct-31-14 08:28PM  Weyerhaeuser (WY) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
10:47AM  [video]Weyerhaeuser Earnings Beat Wall Street Estimates on Timber at TheStreet
10:40AM  Weyerhaeuser Beats on Q3 Earnings, Posts Weak Outlook Zacks
07:50AM  Weyerhaeuser Profit Rises, Outlook Appears Soft at 24/7 Wall St.
07:07AM  Q3 2014 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05:03AM  Weyerhaeuser beats Street 3Q forecasts AP
03:38AM  Weyerhaeuser reports higher third-quarter profit Reuters
03:05AM  Weyerhaeuser Reports Third Quarter Results PR Newswire
Oct-29-14 06:30PM  Will Weyerhaeuser (WY) Miss Earnings Estimates in Q3? Zacks
Oct-15-14 08:14PM  Weyerhaeuser Company Declares Dividend PR Newswire
Oct-14-14 09:45AM  Weyerhaeuser, Elizabeth Arden, Eni, SAP and Sanofi highlighted as Zacks Bull and Bear of the Day Zacks
01:00AM  Bull of the Day: Weyerhaeuser (WY) Zacks
Oct-06-14 01:03PM  3 Real Estate Stocks Dragging The Industry Down at TheStreet
Sep-25-14 02:35PM  Weyerhaeuser to release third quarter results on Oct. 31 PR Newswire
Sep-24-14 01:03PM  3 Stocks Boosting The Real Estate Industry Higher at TheStreet
Sep-19-14 05:16AM  Show of support for Weyerhaeuser optionMONSTER
12:29AM  Marty Whitman's Third Avenue Buys 2 Forest Products Companies Gurufocus
Sep-12-14 01:04PM  3 Stocks Dragging The Financial Sector Downward at TheStreet
Sep-08-14 07:00PM  Weyerhaeuser to hold Investor Meeting on Dec. 9 PR Newswire
06:25PM  Time to Buy the Farm? at The Wall Street Journal
Aug-27-14 04:14PM  Simons, Bedient to Represent Weyerhaeuser at Upcoming Financial Conferences PR Newswire
Aug-26-14 07:28PM  Weyerhaeuser to Move Its Headquarters to Downtown Seattle at Bloomberg
06:34PM  Weyerhaeuser Announces Plans to Move Headquarters to Seattle PR Newswire
10:30AM  Weyerhaeuser Reaches a New 52-Week High on Solid Q2 Earnings Zacks
Aug-15-14 10:40AM  Weyerhaeuser Hikes Dividend, To Buy back $700 Million Shares Zacks
Aug-14-14 03:14PM  Why Weyerhaeuser (WY) Stock Is Gaining Today at TheStreet
07:01AM  [$$] Weyerhaeuser Raises Dividend, Unveils Share Buyback at The Wall Street Journal
Aug-13-14 08:00PM  Weyerhaeuser increases dividend by 32% and announces $700 million share repurchase program PR Newswire
Aug-11-14 10:30AM  Norbord upbeat on Europe but sees no uptick in prices for now Reuters
10:30AM  Norbord upbeat on Europe but sees no uptick in prices for now (Aug 8) Reuters
Aug-08-14 12:12PM  Norbord upbeat on Europe but sees no uptick in prices for now Reuters
Aug-06-14 11:24AM  [video] Apache, AGCO are Deeply Undervalued Says Third Ave Value Manager at TheStreet
Aug-04-14 04:24PM  WEYERHAEUSER CO Files SEC form 10-Q, Quarterly Report EDGAR Online
01:03PM  3 Stocks Boosting The Real Estate Industry Higher at TheStreet
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Merle Denise MSenior Vice PresidentFeb 04Option Exercise23.2911,559269,26027,743Feb 05 05:27 PM
Hunter Rhonda DSr. Vice PresidentFeb 04Option Exercise21.198,441178,84337,029Feb 05 05:27 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 04Option Exercise26.7131,587843,83568,372Feb 05 05:35 PM
Hunter Rhonda DSr. Vice PresidentFeb 04Sale35.268,441297,63428,588Feb 05 05:27 PM
Merle Denise MSenior Vice PresidentFeb 04Sale35.4211,559409,47116,184Feb 05 05:27 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 04Sale35.2631,5871,113,77336,785Feb 05 05:35 PM
Bedient Patricia MExecutive Vice President & CFONov 10Option Exercise23.9215,017359,237173,729Nov 12 12:16 PM
Bedient Patricia MExecutive Vice President & CFONov 10Sale34.5015,017518,087158,712Nov 12 12:16 PM
Bedient Patricia MExecutive Vice President & CFONov 05Option Exercise23.9214,182339,262172,894Nov 06 07:46 PM
Bedient Patricia MExecutive Vice President & CFONov 05Sale34.5014,182489,280158,712Nov 06 07:46 PM
Hunter Rhonda DSr. Vice PresidentAug 27Option Exercise14.8012,242181,21840,266Aug 28 07:33 PM
Hunter Rhonda DSr. Vice PresidentAug 27Sale34.2112,242418,77628,024Aug 28 07:33 PM
Orser Peter MSubsidiary Pres.Jun 05Option Exercise20.0066,4141,328,190133,991Jun 06 06:50 PM
Orser Peter MSubsidiary Pres.Jun 05Sale31.3052,0001,627,59581,991Jun 06 06:50 PM
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E39.62 EPS (ttm)2.93 Insider Own0.20% Shs Outstand793.14M Perf Week0.48%
Market Cap92.08B Forward P/E18.77 EPS next Y6.19 Insider Trans-19.94% Shs Float789.16M Perf Month0.00%
Income2.44B PEG1.57 EPS next Q1.14 Inst Own82.90% Short Float1.77% Perf Quarter-6.24%
Sales8.02B P/S11.48 EPS this Y42.30% Inst Trans-1.34% Short Ratio2.62 Perf Half Y8.52%
Book/sh8.47 P/B13.71 EPS next Y30.16% ROA14.60% Target Price137.62 Perf Year54.31%
Cash/sh9.22 P/C12.59 EPS next 5Y25.23% ROE40.80% 52W Range74.00 - 129.06 Perf YTD3.78%
Dividend- P/FCF31.60 EPS past 5Y23.60% ROI16.30% 52W High-10.05% Beta1.00
Dividend %- Quick Ratio4.40 Sales past 5Y23.30% Gross Margin95.00% 52W Low56.88% ATR2.61
Employees6012 Current Ratio4.60 Sales Q/Q20.30% Oper. Margin38.30% RSI (14)55.10 Volatility1.56% 2.61%
OptionableYes Debt/Eq1.01 EPS Q/Q160.60% Profit Margin30.40% Rel Volume0.50 Prev Close116.20
ShortableYes LT Debt/Eq0.93 EarningsApr 30 BMO Payout0.00% Avg Volume5.34M Price116.09
Recom1.80 SMA202.40% SMA500.08% SMA2006.79% Volume2,650,031 Change-0.09%
Feb-25-15Reiterated Argus Buy $130 → $155
Dec-09-14Reiterated UBS Buy $112 → $130
Dec-09-14Reiterated Argus Buy $102 → $130
Oct-24-14Reiterated Deutsche Bank Buy $115 → $134
Sep-29-14Reiterated RBC Capital Mkts Outperform $100 → $115
Aug-06-14Reiterated RBC Capital Mkts Outperform $95 → $100
Apr-25-14Reiterated Summer Street Research Buy $205 → $184
Mar-19-14Reiterated Summer Street Research Buy $180 → $205
Feb-27-14Reiterated UBS Buy $200 → $209
Jan-28-14Reiterated Deutsche Bank Buy $170 → $190
Jan-14-14Reiterated Brean Capital Buy $191 → $233
Dec-05-13Upgrade UBS Neutral → Buy $163 → $200
Oct-28-13Reiterated Argus Buy $175
Oct-25-13Reiterated Barclays Overweight $158 → $173
Jul-26-13Reiterated Cantor Fitzgerald Buy $156
Jul-26-13Reiterated Barclays Overweight $132 → $158
Jul-26-13Reiterated Argus Hold $160
Jul-17-13Reiterated RBC Capital Mkts Outperform $130 → $145
Jun-13-13Upgrade Argus Hold → Buy $140
Apr-26-13Reiterated Barclays Overweight $113 → $132
May-23-15 09:30AM  The Most Loved Biotechs of Big Hedge Funds at 24/7 Wall St.
May-22-15 02:45PM  A Beautiful Biotech Summer? at Barrons.com
May-21-15 02:18PM  Why Do Biotech Stocks Look Attractive?
01:06PM  Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair at TheStreet
May-20-15 09:34AM  Move Over Chip Stocks: Here Are 5 Top Biotechs at Investor's Business Daily
08:02AM  Move Aside, Chip Stocks, Biotechs Are Leaders Too at Investor's Business Daily
May-19-15 01:50PM  Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog
08:15AM  Analysis of Phase II Data for Celgenes Investigational Oral GED-0301 in Patients with Active Crohns Disease Presented at Digestive Disease Week Business Wire
May-18-15 03:56PM  Celgene, Lannett Lead Boisterous Day For Drugmakers at Investor's Business Daily
11:28AM  Celgene's Crohn's Disease Drug Prompts Lingering Questions at TheStreet
07:39AM  How to play weak Q2 earnings season: Analysts at CNBC
07:30AM  FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Beta-Thalassemia Business Wire
01:00AM  Celgene, Gilead, Netflix, Costco: Jim Cramer's Views
May-16-15 01:19PM  Ask anything: how can I become more consistent as a trader?
May-15-15 02:49PM  Apple Inc. (AAPL), Southwest Airlines Co (LUV), McDonalds Corporation (MCD) Among Long-Term Stock Holdings of Peak6 Investments at Insider Monkey
08:09AM  These 5 Stocks Look Toxic for Your Portfolio in May at TheStreet
May-14-15 04:38PM  5 Things Celgene's Management Wants You to Know at Investopedia
02:32PM  Cancer data deluge
02:07PM  Biotech: Asco Giveth, Asco Taketh Away at Barrons.com
May-13-15 05:18PM  Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2015 Business Wire
02:45PM  This biotech stock is a bargain: Strategist at CNBC
02:40PM  Gilead: No Big Deals at Barrons.com
01:06PM  Healthcare Mid-Day Winners and Losers: May 13, 2015
May-12-15 08:05AM  Short Sellers Start to Get Nervous on Biotech at 24/7 Wall St.
May-11-15 11:45AM  Stevens Capitals Top New Stock Picks Include Celgene Corporation (CELG), Chipotle Mexican Grill, Inc. (CMG) at Insider Monkey
May-08-15 11:47AM  Celgene CEO Says Early-Stage Partnerships Begin to Show Promise at Bloomberg
May-07-15 11:54AM  EU patent office revokes Celgene Revlimid patent; appeal planned Reuters
10:02AM  Celgene: So Much For That Patent Hearing at Barrons.com
09:02AM  Agios (AGIO) Reports Narrower-than-Expected Loss in Q1 - Tale of the Tape
May-06-15 01:04PM  CELGENE CORP /DE/ Financials
09:30AM  The Zacks Analyst Blog Highlights: Celgene, Laboratory Corp. of America Holdings, Quest Diagnostics and Ensign Group - Press Releases
08:46AM  Goldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis Oncology
May-05-15 04:30PM  Will Agios (AGIO) Disappoint this Earnings Season? - Analyst Blog
02:32PM  Sure, the Biotech Sector is Getting Hammered. Here's How to Take Advantage. at Barrons.com
11:21AM  Corporate Earnings, FOMC Drive Financial Markets in May 1 Week
10:30AM  Pfizer, other drug giants to drive biotech
09:48AM  Beyond Pharma: 3 Healthcare Choices - Analyst Blog
07:02AM  The Cancer Drug Market Just Hit $100 Billion And Could Jump 50% In Four Years at Forbes
May-04-15 08:12PM  10-Q for Celgene Corp. at Company Spotlight
10:22AM  No, the Biotech Boom Isn't Over at Barrons.com
May-01-15 02:34PM  Celgene: Just How Worrisome is Its European Patent Hearing? at Barrons.com
11:49AM  A Biotech Bottom? at Barrons.com
10:10AM  Stock Market News for May 01, 2015 - Market News
07:30AM  Analysis of REVLIMID® (Lenalidomide) in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of Life Measures Business Wire
Apr-30-15 06:50PM  Gilead EPS Spikes On Harvoni Drug, Latest HCV Fighter
06:00PM  Market all about 'Eve': Cramer
05:13PM  LinkedIn Sinks On Q2 Outlook, But Apple Supplier Skyworks Gains at Investor's Business Daily
04:45PM  Why Celgene Is Betting on This Tiny Biotech at Investopedia
04:32PM  US STOCKS-Wall St drops with tech shares; indexes up for month
04:16PM  Top-Rated Biotech Unravels Base-Building Effort
04:14PM  Stocks Fall Hard, End Near Lows; Biotechs Slammed Again at Investor's Business Daily
04:09PM  Stocks Slump on Lack of Conviction About Market Direction at TheStreet
04:03PM  Celgene (CELG) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
03:57PM  Celgene sales highlight Revlimid dependence ahead of patent ruling
03:42PM  Celgene Stock Is Poised to 'Scream Back Up' in Q2 at Barrons.com
03:16PM  Stocks Slump in Final Hour; S&P 500, Dow Struggle to Hold April Gains at TheStreet
01:23PM  Celgene Beats on Q1 Earnings, Misses Revenues, Keeps View - Analyst Blog
12:59PM  Top trades for the 2nd half: SWKS, V & FEYE
12:11PM  US STOCKS-Wall St falls on mixed economic data; Apple weighs
10:48AM  Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings at Investor's Business Daily
10:39AM  US STOCKS-Wall St opens lower as Apple, Celgene weigh
10:17AM  Celgene: Light Sales are the Least of Its Problems at Barrons.com
09:30AM  The Zacks Analyst Blog Highlights: Amgen, Celladon, Biogen, Celgene and Gilead - Press Releases
09:21AM  Cramer's Mad Dash: Yelp kept me awake
09:17AM  Morning Movers: Taser Soars on Shocking Earnings; Exxon Gains on Profit, Revenue Beat at Barrons.com
09:03AM  Celgene (CELG) Beats on Q1 Earnings, Shares Down - Tale of the Tape
08:50AM  Is Celgene Stumped on Its Portfolio? at 24/7 Wall St.
08:24AM  Celgene revenue rises less than expected due to strong dollar
08:18AM  Celgene Profit Surges, Driven by Revlimid Sales at The Wall Street Journal
07:56AM  Celgene Reports First Quarter 2015 Operating and Financial Results at noodls
07:56AM  Celgene and Acceleron Select Luspatercept to Advance to Phase 3 in Myelodysplastic Syndromes at noodls
07:51AM  Celgene tops 1Q profit forecasts
07:47AM  Celgene Sales Miss Estimates as Cancer, Psoriasis Drugs Lag at Bloomberg
07:42AM  Celgene profit more than doubles as Revlimid sales shine
07:36AM  CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:30AM  Celgene Reports First Quarter 2015 Operating and Financial Results Business Wire
07:07AM  Q1 2015 Celgene Corp Earnings Release - Before Market Open
Apr-29-15 05:33PM  Market digs for next clue for data dependent Fed at CNBC
03:05PM  What to Expect From Celgene Earnings at 24/7 Wall St.
02:53PM  Midday Glance: Biotechnology companies
02:40PM  Celgene Corporation (CELG), Accelerate Diagnostics Inc (AXDX) and Metabolix, Inc. (MBLX) Among Birchviews Top Bioscience Picks at Insider Monkey
10:45AM  Early Glance: Biotechnology companies
08:51AM  AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers at noodls
08:04AM  Biotech Stock Roundup: Weakness in Biotech Sector on Amgen & Celladon News - Analyst Blog
04:06AM  As US Economy Expands, Innovation Is Tide That Lifts All Boats
Apr-28-15 03:20PM  Will Celgene (CELG) Beat Q1 Earnings on Strong Sales? - Analyst Blog
03:14PM  Celgene to Buy Quanticel, Boost Pipeline Development - Analyst Blog
10:10AM  Stock Market News for April 28, 2015 - Market News
09:50AM  No Bounce for Biotech at Barrons.com
08:02AM  Top Performing Health Care Funds Bruised at Investor's Business Daily
06:05AM  Jim Cramer -- Investors Must Take Care in Riding the Waves of Sea Change at TheStreet
Apr-27-15 06:16PM  Cramer: Wall Street insanity playing a cruel joke? at CNBC
06:00PM  Cramer breaks down today's sea-change in stocks
05:27PM  Anticlimactic: Stocks Sink After Record Breaking Week at Barrons.com
03:07PM  There Go the Biotechs at Barrons.com
01:16PM  Biotechs Weigh On Nasdaq, But Apple, Twitter Hold Firm at Investor's Business Daily
10:50AM  AstraZeneca & Celgene: 'Perplexing' at Barrons.com
09:50AM  AstraZeneca Falls on Q1 Earnings Decline, Reiterates View - Analyst Blog
08:30AM  Short Sellers Become More Wary of Big Biotech at 24/7 Wall St.
08:02AM  Celgene to Acquire Quanticel Pharmaceuticals at noodls
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML). The company's products also include THALOMID for the patients with multiple myeloma and for the treatment of cutaneous manifestations of erythema nodosum leprosum; OTEZLA for psoriatic arthritis, psoriasis, and ankylosing spondylitis; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. Its clinical stage products comprise oral anti-inflammatory agents targeting PDE4, an intracellular enzyme that modulates the production of multiple pro-inflammatory and anti-inflammatory mediators; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; cellular therapies, such as PDA-001 and PDA-002 for Crohn's and peripheral arterial diseases; CC-486 to treat MDS, AML, and solid tumors; Sotatercept and luspatercept for the treatment of anemia; and CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; MorphoSys AG; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; and NantBioScience, Inc. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
STEIN LAWRENCE VSee RemarksMay 14Option Exercise39.332,54299,97716,591May 15 04:30 PM
STEIN LAWRENCE VSee RemarksMay 14Sale114.852,542291,94914,049May 15 04:30 PM
KARSEN PERRY Asee remarksMay 13Option Exercise48.9430,4701,491,296109,993May 15 04:29 PM
Smith Scott AndrewSee RemarksApr 30Option Exercise0.006,666022,510May 04 07:16 PM
HUGIN ROBERT Jsee remarksApr 30Option Exercise0.0064,00001,217,315May 04 07:15 PM
KARSEN PERRY Asee remarksApr 30Option Exercise0.0011,200085,330May 04 07:15 PM
Daniel Thomas Osee remarksApr 30Option Exercise0.0011,200061,376May 04 07:14 PM
FOUSE JACQUALYN Asee remarksApr 30Option Exercise0.0011,200059,403May 04 07:14 PM
Alles Mark JSee RemarksApr 30Option Exercise0.0011,2000116,601May 04 07:13 PM
KARSEN PERRY Asee remarksMar 01Option Exercise0.008,334078,451Mar 03 04:24 PM
Daniel Thomas Osee remarksMar 01Option Exercise0.008,334054,524Mar 03 04:23 PM
FOUSE JACQUALYN Asee remarksMar 01Option Exercise0.008,334052,140Mar 03 04:24 PM
Alles Mark JSee RemarksMar 01Option Exercise0.008,3340109,479Mar 03 04:22 PM
KAPLAN GILLADirectorFeb 26Option Exercise8.4715,000127,02094,508Feb 27 04:14 PM
KAPLAN GILLADirectorFeb 26Sale122.8915,0001,843,35079,508Feb 27 04:14 PM
CASEY MICHAEL DDirectorFeb 25Option Exercise8.4715,000127,02015,000Feb 27 04:13 PM
CASEY MICHAEL DDirectorFeb 25Sale123.1915,0001,847,7900Feb 27 04:13 PM
Alles Mark JSee RemarksFeb 12Option Exercise45.4327,5051,249,653101,145Feb 17 04:44 PM
KARSEN PERRY Asee remarksFeb 11Option Exercise37.5227,8961,046,52098,013Feb 13 05:07 PM
KARSEN PERRY Asee remarksFeb 11Sale120.1227,8963,350,72870,117Feb 13 05:07 PM
Alles Mark JSee RemarksFeb 06Option Exercise41.75107,8594,503,114174,001Feb 10 06:46 PM
Alles Mark JSee RemarksFeb 06Sale120.68117,09914,131,15656,902Feb 10 06:46 PM
MARIO ERNESTDirectorFeb 03Option Exercise27.697,666212,272137,024Feb 04 04:11 PM
STEIN LAWRENCE VSee RemarksJan 15Option Exercise39.3324,124948,79730,858Jan 20 04:11 PM
STEIN LAWRENCE VSee RemarksJan 15Sale120.0126,6663,200,2534,192Jan 20 04:11 PM
KAPLAN GILLADirectorJan 02Option Exercise16.2145,536738,25245,536Jan 06 04:17 PM
KAPLAN GILLADirectorJan 02Sale113.4745,5365,167,1340Jan 06 04:17 PM
KARSEN PERRY Asee remarksDec 30Option Exercise29.7523,334694,18774,744Jan 02 04:01 PM
KARSEN PERRY Asee remarksDec 30Sale113.3719,2732,184,98055,471Jan 02 04:01 PM
Daniel Thomas Osee remarksDec 15Option Exercise29.7530,000892,50075,400Dec 17 04:03 PM
Daniel Thomas Osee remarksDec 15Sale115.0630,0003,451,87245,400Dec 17 04:03 PM
KAPLAN GILLADirectorDec 08Option Exercise7.0915,000106,38894,508Dec 10 04:41 PM
KAPLAN GILLADirectorDec 08Sale118.2015,0001,773,00079,508Dec 10 04:41 PM
Smith Scott AndrewSee RemarksNov 30Option Exercise0.006,67006,670Dec 02 04:14 PM
Daniel Thomas Osee remarksNov 24Option Exercise0.0033,818079,218Nov 26 04:32 PM
Daniel Thomas Osee remarksNov 24Sale110.2733,8183,729,11145,400Nov 26 04:32 PM
KARSEN PERRY Asee remarksNov 12Option Exercise32.9032,0741,055,39190,830Nov 14 04:13 PM
KARSEN PERRY Asee remarksNov 12Sale107.2339,4204,227,00751,410Nov 14 04:13 PM
HUGIN ROBERT Jsee remarksNov 03Option Exercise14.35744,40010,683,7501,769,158Nov 04 04:07 PM
HUGIN ROBERT Jsee remarksNov 03Sale106.68158,00016,855,4401,177,300Nov 04 04:07 PM
MARIO ERNESTDirectorOct 27Sale102.85100,00010,284,630129,358Oct 29 04:09 PM
CASEY MICHAEL DDirectorOct 24Option Exercise7.0915,000106,38815,000Oct 28 04:08 PM
CASEY MICHAEL DDirectorOct 24Sale102.9415,0001,544,1080Oct 28 04:08 PM
KAPLAN GILLADirectorSep 08Option Exercise7.2530,000217,425109,508Sep 10 05:14 PM
KAPLAN GILLADirectorSep 08Sale93.7330,0002,811,90079,508Sep 10 05:14 PM
KARSEN PERRY Asee remarksAug 04Option Exercise28.1646,4501,308,03297,860Aug 05 04:14 PM
KARSEN PERRY Asee remarksAug 04Sale87.5539,1043,423,43458,756Aug 05 04:14 PM
BARKER RICHARD WDirectorJul 25Option Exercise31.8018,600591,38723,562Jul 28 04:46 PM
BARKER RICHARD WDirectorJul 25Sale87.0317,6001,531,6585,962Jul 28 04:46 PM
MARIO ERNESTDirectorJul 24Option Exercise27.695,000138,450229,358Jul 28 04:45 PM
MARIO ERNESTDirectorJun 15Option Exercise0.003,1000111,837Jun 16 06:57 PM
CASEY MICHAEL DDirectorJun 15Option Exercise0.001,03403,100Jun 16 06:53 PM
DRAKE RODMAN LDirectorJun 15Option Exercise0.001,034026,180Jun 16 06:54 PM
BARKER RICHARD WDirectorJun 13Option Exercise0.001,03302,790Jun 16 06:52 PM
DRAKE RODMAN LDirectorJun 13Option Exercise0.00516025,146Jun 16 06:54 PM
CASEY MICHAEL DDirectorJun 13Option Exercise0.001,03302,066Jun 16 06:53 PM
Friedman Michael ADirectorJun 13Option Exercise0.001,03303,099Jun 16 06:55 PM
KAPLAN GILLADirectorJun 13Option Exercise0.001,033039,754Jun 16 06:56 PM
LOUGHLIN JAMES JDirectorJun 13Option Exercise0.001,03308,509Jun 16 06:56 PM
MARIO ERNESTDirectorJun 13Option Exercise0.001,0330108,737Jun 16 06:57 PM
MARIO ERNESTDirectorJun 12Option Exercise0.001,0330107,704Jun 16 06:57 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.001,03307,476Jun 16 06:56 PM
KAPLAN GILLADirectorJun 12Option Exercise0.001,033038,721Jun 16 06:56 PM
Friedman Michael ADirectorJun 12Option Exercise0.001,03302,066Jun 16 06:55 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.001,03301,033Jun 16 06:53 PM
DRAKE RODMAN LDirectorJun 12Option Exercise0.001,033024,630Jun 16 06:54 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.001,03302,066Jun 16 06:52 PM
KAPLAN GILLADirectorJun 09Option Exercise13.6815,000205,12552,688Jun 11 04:02 PM
CASEY MICHAEL DDirectorJun 09Option Exercise13.6815,000205,12515,000Jun 11 04:01 PM
KAPLAN GILLADirectorJun 09Sale161.6215,0002,424,29437,688Jun 11 04:02 PM
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E25.35 EPS (ttm)4.10 Insider Own0.20% Shs Outstand1.13B Perf Week1.84%
Market Cap117.29B Forward P/E17.59 EPS next Y5.91 Insider Trans-25.11% Shs Float1.13B Perf Month3.04%
Income4.74B PEG1.70 EPS next Q1.20 Inst Own84.90% Short Float0.80% Perf Quarter1.02%
Sales143.01B P/S0.82 EPS this Y5.90% Inst Trans-2.10% Short Ratio2.06 Perf Half Y16.84%
Book/sh32.79 P/B3.17 EPS next Y14.19% ROA6.40% Target Price115.00 Perf Year36.52%
Cash/sh1.45 P/C71.78 EPS next 5Y14.88% ROE12.50% 52W Range73.61 - 105.10 Perf YTD8.69%
Dividend1.40 P/FCF26.54 EPS past 5Y9.30% ROI10.30% 52W High-1.09% Beta1.07
Dividend %1.35% Quick Ratio0.70 Sales past 5Y7.20% Gross Margin17.90% 52W Low41.23% ATR1.46
Employees137800 Current Ratio1.30 Sales Q/Q11.10% Oper. Margin6.20% RSI (14)62.81 Volatility1.57% 1.48%
OptionableYes Debt/Eq0.35 EPS Q/Q12.60% Profit Margin3.30% Rel Volume0.84 Prev Close103.69
ShortableYes LT Debt/Eq0.32 EarningsMay 01 BMO Payout28.50% Avg Volume4.39M Price103.95
Recom1.70 SMA203.06% SMA502.18% SMA20012.56% Volume3,671,155 Change0.25%
May-22-15Reiterated Jefferies Buy $120 → $125
Feb-13-15Reiterated Deutsche Bank Hold $100 → $109
Feb-11-15Reiterated RBC Capital Mkts Outperform $108 → $115
Feb-11-15Reiterated Mizuho Buy $103 → $113
Feb-11-15Reiterated Argus Buy $104 → $114
Dec-18-14Reiterated Argus Buy $95 → $105
Dec-17-14Reiterated RBC Capital Mkts Outperform $96 → $103
Nov-12-14Reiterated Mizuho Buy $85 → $103
Nov-05-14Reiterated RBC Capital Mkts Outperform $86 → $96
Nov-05-14Reiterated Argus Buy $85 → $95
Aug-06-14Reiterated RBC Capital Mkts Outperform $76 → $86
Aug-06-14Reiterated Mizuho Buy $81 → $85
Aug-06-14Reiterated Argus Buy $83 → $85
Aug-05-14Reiterated ISI Group Strong Buy $86 → $88
May-19-14Initiated Standpoint Research Strong Sell $62
May-05-14Reiterated Barclays Overweight $74 → $85
Apr-04-14Reiterated Argus Buy $77 → $83
Jan-22-14Upgrade ISI Group Buy → Strong Buy
Dec-19-13Reiterated RBC Capital Mkts Outperform $71 → $76
Dec-19-13Reiterated Mizuho Buy $74 → $81
May-24-15 05:02PM  Was CVS' cigarettes decision the right one? at USA TODAY
May-23-15 12:01AM  Follow Up at Barrons.com
May-22-15 09:04PM  Saluting the Monster Wave in Health Care Mergers and Recognizing Signs of a True Recovery: Jim Cramer's Best Blogs at TheStreet
05:13PM  CVS HEALTH CORP Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
03:43PM  WeissLaw LLP: Omnicare, Inc. Acquisition by CVS Health Corporation May Not be In The Best Interest of OCR Shareholders PR Newswire
02:30PM  CVS Health to Buy Omnicare for $12.7B; Eyes Specialty Care - Analyst Blog
12:41PM  Heres What Happened After CVS Stopped Selling Cigarettes
11:00AM  The word is this company could be the target of the next big healthcare deal and now the stock is at an all time high
11:00AM  12 Worst Buys in Funds at Forbes
10:08AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Omnicare Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to CVS Health Corp. -- OCR PR Newswire
10:05AM  CVS Health (CVS) Stock Price Target Increased by Analysts at TheStreet
10:00AM  3 Consumer ETFs to Gain on CVS Health Buyout - ETF News And Commentary
09:30AM  The Zacks Analyst Blog Highlights: Wal-Mart Stores, Amazon.com, Jack in the Box, American Eagle Outfitters and CVS Health - Press Releases
09:05AM  May 22 Premarket Briefing: 10 Things You Should Know
08:53AM  How Pricey Specialty Drugs Spurred CVS Health's Omnicare Deal at Forbes
07:50AM  Five things you need to know today, and Cincinnati loses a Fortune 500 company at bizjournals.com
07:48AM  CVS Health Surges on Heavy Trade, Heading for New Highs at TheStreet
07:43AM  In a quiet stock market, whispers of an M&A wave
06:00AM  Lean times for the diet industry at Fortune
06:00AM  Jim Cramer: Heres One of the Stupidest Things Investors Do at TheStreet
12:44AM  [$$] CVS Ages Gracefully With Omnicare Deal at The Wall Street Journal
May-21-15 07:35PM  As Express Scripts Attacks Costs, Investors Will Profit at Barrons.com
07:24PM  Cramer Remix: Why you need to avoid Chinese stocks at CNBC
07:10PM  5 plays on big-name retail stocks at CNBC
06:35PM  Cramer: Mergers that could unlock riches for you at CNBC
06:21PM  As CVS Swoops Up Old Suitor, PharMericas Single and Loving It at Bloomberg
06:13PM  Cramer: Stupid decisions ruining your portfolio at CNBC
06:05PM  CVS Health Buys Omnicare, Citing 'Long-Term' Benefits at Investor's Business Daily
06:05PM  CVS Health Buys Omnicare, Citing 'Long-Term' Benefits
06:00PM  Cramer: Snap judgments, stupid decisions
05:31PM  CVS HEALTH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements an
05:00PM  Trading retail: 5 plays on 3 stocks
05:00PM  Stocks End Higher After Disappointing Data
04:53PM  Omnicare, Inc. -- Moody's reviews Omnicare's Ba3 CFR for upgrade on pending acquisition by CVS at Moody's
04:42PM  CVS buys Omnicare for $12.7B to expand senior care business at USA TODAY
04:39PM  CVS to Buy Omnicare in $12.7 Billion Pharmacy Expansion Deal
04:36PM  'Fast Money Halftime' Recap: Is Netflix Still a Buy? at TheStreet
04:07PM  What's Behind CVS's $12.7 Billion Takeover of Omnicare at TheStreet
03:34PM  CVS paying $10.4B in cash for drug distributor Omnicare
03:04PM  CVS' $12.7 Billion Buy of Omnicare Is a Winner at Barrons.com
03:01PM  3 Retail Stocks that Outperformed Wal-Mart in Q1 - Analyst Blog
02:52PM  CVS Buys Omnicare: What About the Buybacks? at Barrons.com
02:40PM  Robbins Arroyo LLP: Acquisition of Omnicare Inc. (OCR) by CVS Health Corporation (CVS) May Not Be in Shareholders' Best Interests PR Newswire
02:29PM  CVS Ages Gracefully With Omnicare Deal at The Wall Street Journal
02:09PM  Harwood Feffer LLP Announces Investigation of Omnicare, Inc. PR Newswire
01:52PM  OMNICARE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
01:10PM  Longs Drugs parent CVS to buy Ohio-based drug distributor in $13B deal at bizjournals.com
12:33PM  CVS Chief Bets Big on Health Care Thrust With Omnicare Deal at Bloomberg
12:00PM  Stocks Higher; Disappointing Data in Focus
11:17AM  CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B at TheStreet
11:15AM  CVS to buy Ohio-based drug distributor in $13B deal at bizjournals.com
11:09AM  Top 10 Most Popular American Stores
10:51AM  CVS to spend $10.4B in cash on drug distributor Omnicare
10:45AM  CVS capitalizes on the graying of America with $12.7B Omnicare buy
10:02AM  CVS Health (CVS) Stock Gains After $12.7 Billion Omnicare Purchase at TheStreet
09:23AM  CVS to spend $10.4 billion in cash on drug distributor Omnicare at Los Angeles Times
09:19AM  Omnicare (OCR) Stock Higher After CVS Agrees to Acquisition at TheStreet
09:03AM  Best Buy soars on big beat; CVS buys Omnicare; NetApp hits 52-week low
08:52AM  CVS Seeks Seniors, Specialty Pharmacy In $12.7B Omnicare Deal at Forbes
08:47AM  CVS to spend $10.4 B in cash on drug distributor Omnicare
08:38AM  Traders Sell The News In Omnicare: CVS Confirms Deal To Purchase At $98/Share In Cash
08:15AM  Investors eye housing data; Best Buy's best day; Shake Shack chickens out?
07:42AM  CVS buying Omnicare for about $12.7 billion
07:40AM  Five things you need to know today, and the road to change starts right here, right now at bizjournals.com
07:28AM  CVS to buy Omnicare for $12.7 billion at MarketWatch
07:13AM  CVS to Buy Omnicare in $12.7 Billion Deal for Pharmacy Expansion
07:00AM  CVS Health and Omnicare Sign Definitive Agreement for CVS Health to Acquire Omnicare PR Newswire
May-20-15 07:45PM  CVS nears deal to buy Omnicare for more than $12 billion: sources
07:39PM  CVS nears deal to buy Omnicare for more than $12 bln -sources
07:11PM  CVS Said in Advanced Talks to Buy Omnicare to Expand Pharma
06:47PM  CVS Health in advanced talks to buy pharmacy service provider Omnicare -Bloomberg
05:59PM  CVS Said in Advanced Talks to Buy Omnicare in Pharmacy Expansion at Bloomberg
May-19-15 03:51PM  Who are Rite Aid's (RAD) main competitors? at Investopedia
02:27PM  Anatomy of a trade - CVS
09:35AM  CVS/pharmacy Rewards Loyal Shoppers with New "CVSCash Card" Promotion PR Newswire
09:00AM  Most I.D. Theft is of the Local, No-Tech Variety at Fox Business
May-18-15 02:49PM  Endo buying Par for $8B in push for generics, higher profit
12:45PM  Wet wipe maker agrees to roll back flushing claims at CNBC
May-16-15 07:53AM  5 Mistakes to Avoid for the Rest of 2015 at Forbes
May-14-15 01:54PM  Business events scheduled for Friday
06:35AM  The Most Popular Stores in America at 24/7 Wall St.
May-13-15 06:08PM  CVS pays $22 mln to resolve Florida painkiller probe Reuters
05:11PM  Smokers have better luck quitting when own money wagered
05:01PM  CVS Health Research Institute Study Finds Smoking Cessation Programs with Financial Incentives Increase Rates of Quitting and Staying Smoke-free PR Newswire
01:19PM  CVS will pay $22M in investigation into Fla. pharmacies
11:43AM  CVS HEALTH CORP Files SEC form 8-K, Regulation FD Disclosure
May-12-15 01:56PM  Aetna Merger With Cigna or Humana Could Be 'Imminent' at Barrons.com
11:57AM  Blue Ridge Capital Lowered Its Position in Walgreens Boots Alliance
08:00AM  MinuteClinic Reaches 25 Million Patient Visit Milestone PR Newswire
May-11-15 05:27PM  Compass Capital Management's Top 3 Picks During Q1
12:22PM  Richard Pzena Makes 12 New Buys in First Quarter
May-08-15 04:45PM  CVS HEALTH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03:35PM  Cancer drug spending hit $100 billion in 2014. Heres why itll soon be much higher at Fortune
May-07-15 04:45PM  Rite Aid (RAD) Announces JV Between RediClinic & MultiCare - Analyst Blog
01:29PM  CVS Health To Present At Upcoming Conferences at noodls
12:00PM  CVS Health To Present At Upcoming Conferences PR Newswire
11:37AM  Advent brings IPO of perfume chain Douglas forward - sources Reuters
08:47AM  CVS Health Publishes 2014 Corporate Social Responsibility Report at noodls
08:30AM  CVS Health Publishes 2014 Corporate Social Responsibility Report PR Newswire
May-06-15 04:40PM  CVS to rebuild Baltimore locations damaged during protests
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private organizations, other sponsors of health benefit plans, and individuals under the CVS/caremark Pharmacy Services, Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, Coram CVS/specialty, NovoLogix, and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. As of December 31, 2014, it operated 7,822 retail drugstores, 860 health care clinics, 17 onsite pharmacy stores, 27 retail specialty pharmacy stores, 11 specialty mail order pharmacies, 4 mail service dispensing pharmacies, and 86 branches, as well as 6 centers of excellence for infusion and enteral services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROWN C DAVID IIDirectorMay 01Sale100.2715,0001,504,050101,252May 04 04:41 PM
Sussman AndrewEVP & Pres, CVS/minuteclinicApr 10Option Exercise49.5212,556621,72220,598Apr 13 04:20 PM
Sussman AndrewEVP & Pres, CVS/minuteclinicApr 10Sale102.3817,6381,805,8298,861Apr 13 04:20 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 02Option Exercise45.0716,637749,83078,478Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 02Sale102.7116,6371,708,78661,841Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 01Option Exercise34.9616,747585,47574,257Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerApr 01Sale102.2616,7471,712,54857,510Apr 03 04:56 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 23Option Exercise45.0733,2741,499,65988,360Mar 24 04:12 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 23Sale104.9433,2743,491,77455,086Mar 24 04:12 PM
BROWN C DAVID IIDirectorMar 20Sale104.3025,0002,607,500116,252Mar 23 04:19 PM
Roberts Jonathan CEVP & President, CVS/caremarkJan 07Option Exercise41.1786,4873,560,670117,955Jan 08 04:12 PM
Roberts Jonathan CEVP & President, CVS/caremarkJan 07Sale95.3186,4878,243,07631,468Jan 08 04:12 PM
MERLO LARRY JPresident and CEOJan 05Option Exercise41.17144,1445,934,408220,273Jan 06 05:33 PM
MERLO LARRY JPresident and CEOJan 05Sale94.30144,14413,592,77976,129Jan 06 05:33 PM
Lofberg Per GHEVPJan 02Option Exercise45.07347,34315,654,749370,762Jan 05 04:52 PM
Brennan Troyen AEVP, Chief Medical OfficerJan 02Option Exercise34.9650,2401,756,39091,487Jan 05 04:58 PM
Sussman AndrewSVP & Pres, CVS/minuteclinicJan 02Sale95.674,220403,7132,817Jan 05 05:00 PM
Brennan Troyen AEVP, Chief Medical OfficerJan 02Sale95.7150,2404,808,51641,247Jan 05 04:58 PM
Lofberg Per GHEVPJan 02Sale95.28347,34333,096,43923,419Jan 05 04:52 PM
Foulkes HelenaEVP, President-CVS/pharmacyNov 07Option Exercise39.3246,3251,821,35838,040Nov 10 05:11 PM
Foulkes HelenaEVP, President-CVS/pharmacyNov 07Sale88.0646,3254,079,58418,076Nov 10 05:11 PM
Bisaccia LisaSVP, Chief HR OfficerOct 27Option Exercise40.6527,5861,121,39538,730Oct 28 04:07 PM
Bisaccia LisaSVP, Chief HR OfficerOct 27Sale85.0033,5072,848,09517,281Oct 28 04:07 PM
Sussman AndrewSVP & President, MinuteClinicSep 02Option Exercise36.969,020333,37916,057Sep 03 04:43 PM
Sussman AndrewSVP & President, MinuteClinicSep 02Sale79.459,020716,6397,037Sep 03 04:43 PM
Joyner J. DavidEVP, Sales & Account ServicesAug 06Option Exercise31.12123,5163,843,942123,018Aug 07 04:14 PM
Joyner J. DavidEVP, Sales & Account ServicesAug 06Sale76.10123,5169,399,56845,399Aug 07 04:14 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 21Option Exercise30.1622,107666,74739,870Jul 22 04:22 PM
Boratto Eva CSVP, Cont & Chief Acct OfficerJul 21Sale76.7722,1071,697,15417,763Jul 22 04:22 PM
Denton David MEVP, CFOJul 01Option Exercise32.7774,9892,457,611161,873Jul 03 04:13 PM
Denton David MEVP, CFOJul 01Sale75.8874,9895,690,16586,884Jul 03 04:13 PM
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.97%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month0.47%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter3.70%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y10.51%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year28.89%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range57.66 - 76.01 Perf YTD9.96%
Dividend0.97 P/FCF- EPS past 5Y- ROI- 52W High-1.36% Beta-
Dividend %1.29% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low30.04% ATR0.76
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)61.41 Volatility0.71% 1.08%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.50 Prev Close75.16
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.17M Price74.98
Recom- SMA202.08% SMA502.18% SMA2009.56% Volume4,612,115 Change-0.24%
May-23-15 08:19AM  What You Need To Know About This Higher Risk Stage Of The Bull Market
May-22-15 01:56PM  3 Smart summer trades
12:06PM  What Is the Expected Timing of the PallDanaher Transaction?
12:06PM  Danaher Intends to Split Up Next Year
07:00AM  Scouring S&P 500 Sectors For Bargains at Morningstar
May-21-15 03:57PM  Pall-Danaher Transaction: What You Should Know about Danaher
03:57PM  Pall-Danaher Transaction: An Overview of Pall
11:42AM  Basics of the PallDanaher Transaction
11:41AM  The PallDanaher Spread is Trading Like a Safe Deal
May-19-15 11:21AM  Will Healthcare and Biotech Propel Stocks Higher? at Forbes
May-15-15 10:16AM  Solid Jobs Growth Points to US Economic Health
09:23AM  These 4 ETFs Are Outpacing the Broader Stock Market at TheStreet
08:04AM  UHS CEO: Information, transforming health care
May-14-15 04:02PM  HospiraPfizer Deal Update: Shareholder Approval, 2nd Request
11:06AM  Should You Set Up the Synageva BioPharmaAlexion Spread?
10:06AM  Times Like These Call for Factor Funds
08:52AM  Adding a Factor Fund Gives You Tactical Exposure
May-13-15 03:07PM  Alexion Pharmaceuticals: A Focus on Treating Rare Disorders
03:07PM  Synageva BioPharma: A Pipeline of Therapeutic Programs
06:44AM  Your prescriptions costs what?
May-12-15 04:25PM  The SynagevaAlexion Merger: Stock and Cash Considerations
04:25PM  Alexion Pharmaceuticals Pays up to Get Synageva BioPharma
11:56AM  Blue Ridge Capital Reduces Position in Actavis
May-11-15 12:22PM  Talk Of A Stock Market Crash How Concerned Should We Be?
10:00AM  Late-Cycle Fervor Lifts Leveraged Materials ETF
09:05AM  Increased Medical Costs Affect Humanas EBITDA Margins in 1Q15
09:01AM  These Three Stocks Stressed Hedge Funds the Most Last Week
05:05AM  What Investors Can Expect from Pfizer in 2015
05:04AM  What Is the Risk-to-Reward on the PerrigoMylan Situation?
04:05AM  How the Mylan Bid Stacks Up to Similar Transactions
04:04AM  Whats the Spread in the PerrigoMylan transaction?
03:06AM  Humanas Commercial Enrollments Face Pressure in 1Q15
03:06AM  Humanas 1Q15 Medicare PDP and Medicaid Enrollments See Solid Growth
03:05AM  Teva Remains Committed to the Transaction with Mylan
May-10-15 10:01AM  How A $1.2 Billion Mutual Fund Manager Is Gearing Up For The Next Bear Market at Forbes
May-09-15 10:05PM  Pfizer Stock Dips over 1Q15 Forward Valuation Concerns
May-08-15 07:41PM  The Week Ahead: Are These Key Markets Changing Direction? at Forbes
01:02PM  A Quick Guide To Healthcare ETFs at Investopedia
12:06PM  Pfizer Revenues Hit by Lost Exclusivity in 1Q15
12:06PM  Pfizers Exposure to Overseas Markets Soaks 1Q15 Revenues
10:06AM  High Medical Costs Affect Centenes EBITDA Margins in 1Q15
01:06AM  Centenes 1Q15 Enrollments Increase in Key Sectors
01:06AM  Market Expansion Strategy Supports Centenes Growth in 1Q15
May-07-15 10:05PM  Universal Health Services Market Mix and Payer Mix Impact 1Q15
10:05PM  1Q15 Earnings Preview: HCA Holdings Stock Up 12.6%
05:47PM  Two Health Care ETFs With The Most Growth Potential: S&P Capital IQ at Forbes
01:44PM  Strong Medicare Advantage Enrollments Help Humana in 1Q15
01:42PM  Key Takeaways from Humanas 1Q15 Earnings Release
10:41AM  We're unique & biggest in healthcare: Athenahealth CEO
09:05AM  HCA Holdings: Will High-Income Markets Reduce Bad Debt in 1Q15?
09:05AM  HCA Holdings in 2015: Operating Expenses May Hit Margins
08:11AM  Sell The Inflation Trade?
May-06-15 11:07AM  Reduced Expenses Lead to Aetnas Higher 1Q15 Margins
09:06AM  Shares Rise 2% after Novartis Posts 1Q15 Earnings
08:37AM  GSK CEO: Our 3 key areas of strength
01:06AM  Aetnas Commercial Enrollments Increase 1Q15 Revenues
01:06AM  Pharmacy and Payment Strategy Add to Aetnas 1Q15 Growth
May-05-15 09:06PM  Why Novartiss Operating Margins Expanded in 1Q15
05:05PM  Admissions Expected to Drive HCA Holdings Revenues In 1Q15
04:06PM  Anthem Has Increased by ~13% Since 4Q14 Earnings Release
02:15PM  Predictions for first-quarter earnings arent panning out at MarketWatch
11:07AM  Universal Health Services Controls Operating and Capital Expenses
11:07AM  Universal Health Services Behavioral Health Segment Is Strong
11:06AM  Increased 1Q15 Costs to Hurt Anthems EBITDA Margins
11:06AM  Modest Commercial Enrollment Growth to Help Anthem in 1Q15
08:18AM  Tenet reports healthy Q1 results
07:04AM  Q1 earnings scorecard
May-04-15 10:06PM  Cignas Shares Up by 16.4% Since Its Previous Earnings Release
10:06PM  Cignas Increased Costs in 1Q15 Will Affect Its EBITDA Margins
02:06PM  Cigna Expects $1.8 Billion Spending for Capital Investments
02:06PM  Growing Medicare Advantage Expected to Boost Cignas 1Q15 Revenue
01:32PM  Strong Government-Sponsored Enrollments Help Centene in 1Q15 Market Realist
01:32PM  Key Takeaways from Centenes 1Q15 Earnings Release
12:44PM  This sector is a 'win-win' trade: Technician at CNBC
May-01-15 02:38PM  Top picks in health care
02:21PM  Sell in May and go away at your own peril at CNBC
10:45AM  Energy ETF Rally has Options Bears Waving the White Flag
Apr-30-15 10:05PM  Mylan Shareholders Well Placed in the MylanTeva Deal
11:25AM  Government-Sponsored Enrollments Boost Aetnas 1Q15 Revenues
11:24AM  Key Takeaways from Aetnas 1Q15 Earnings Release
09:36AM  Pisani's market open mixed
09:05AM  Strength of the US Dollar Takes a Toll on Novartis Revenues
Apr-29-15 01:29PM  Perrigo Rejects Mylans Increased Offer
01:18PM  Mylan Bumps Up Offer for Perrigo
01:03PM  The PerrigoMylan Proposal Faces some Big Hurdles
01:03PM  Mylan Launches Hostile Bid for Perrigo
12:17PM  United Health Services Acute Care Revenue Increases in 1Q15
12:17PM  Highlights from Universal Health Services 1Q15 Earnings Release
12:07PM  Mylan Versus Teva Pharmaceuticals: Takeover Defenses Are Weak
09:30AM  Small-Cap Sector ETFs to buy in May
05:06AM  How Much Can Teva Pharmaceuticals Afford to Pay for Mylan?
05:06AM  What Stage of the Business Cycle Are We In Now?
04:06AM  As US Economy Expands, Innovation Is Tide That Lifts All Boats
Apr-28-15 05:06PM  Humanas Shares Up by 18.8% since Its Previous Earnings
04:34PM  Pockets Of Value Persist In Sectors As Energy Makes Overall Market Look Fat at Forbes
03:17PM  Need new drug payment model: Aetna CEO
02:23PM  Government-Sponsored Enrollments to Drive Anthems 2015 Revenues
02:20PM  What to Expect from Anthems 1Q15 Earnings
01:39PM  Reason to be optimistic in biotech: Pro
01:20PM  Mylans Objections to Tevas Offer
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG [NYSE]
ConAgra Foods, Inc.
IndexS&P 500 P/E- EPS (ttm)-2.70 Insider Own0.20% Shs Outstand427.05M Perf Week0.94%
Market Cap16.59B Forward P/E17.16 EPS next Y2.26 Insider Trans-62.77% Shs Float424.99M Perf Month4.27%
Income-1146.60M PEG- EPS next Q0.59 Inst Own76.10% Short Float1.70% Perf Quarter13.27%
Sales16.18B P/S1.03 EPS this Y-62.20% Inst Trans1.44% Short Ratio2.87 Perf Half Y10.71%
Book/sh10.43 P/B3.72 EPS next Y4.14% ROA-4.10% Target Price35.78 Perf Year26.59%
Cash/sh0.32 P/C120.84 EPS next 5Y8.47% ROE-15.00% 52W Range27.78 - 38.98 Perf YTD8.55%
Dividend1.00 P/FCF34.93 EPS past 5Y-12.30% ROI4.20% 52W High-0.33% Beta0.45
Dividend %2.57% Quick Ratio0.40 Sales past 5Y7.50% Gross Margin20.30% 52W Low39.83% ATR0.47
Employees32800 Current Ratio1.10 Sales Q/Q-1.80% Oper. Margin-4.00% RSI (14)73.63 Volatility1.06% 1.27%
OptionableYes Debt/Eq1.88 EPS Q/Q-528.80% Profit Margin-4.90% Rel Volume0.90 Prev Close38.88
ShortableYes LT Debt/Eq1.55 EarningsJun 30 BMO Payout- Avg Volume2.52M Price38.85
Recom3.00 SMA203.54% SMA505.81% SMA20011.98% Volume2,255,728 Change-0.08%
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-12-14Reiterated Deutsche Bank Hold $35 → $31
Nov-26-13Initiated RBC Capital Mkts Sector Perform $33
Sep-11-13Reiterated Barclays Overweight $40 → $38
Apr-03-13Reiterated Deutsche Bank Hold $35 → $40
Feb-20-13Reiterated Deutsche Bank Hold $31 → $32
Jan-24-13Reiterated UBS Buy $38 → $36
Nov-28-12Reiterated Deutsche Bank Hold $29 → $31
Sep-21-12Upgrade UBS Neutral → Buy $27 → $31
Jul-25-12Initiated KeyBanc Capital Mkts Buy $30
May-05-11Reiterated Deutsche Bank Hold $23 → $28
Sep-22-10Reiterated Barclays Capital Equal Weight $27 → $25
Sep-17-10Reiterated Deutsche Bank Hold $26 → $25
Mar-22-10Reiterated Credit Suisse Neutral $24 → $27
Sep-23-09Reiterated Credit Suisse Neutral $21 → $24
Jun-23-09Upgrade UBS Neutral → Buy
Jun-15-09Downgrade Citigroup Buy → Hold
Mar-27-09Upgrade Bernstein Underperform → Mkt Perform
Mar-25-09Reiterated Credit Suisse Neutral $18 → $16
Dec-18-08Reiterated UBS Neutral $15 → $17
May-22-15 01:14PM  Egg-pocalypse? Stocks to Watch as Chicken and Egg Prices Continue to Spike at TheStreet
07:43AM  In a quiet stock market, whispers of an M&A wave
06:00AM  Lean times for the diet industry at Fortune
May-21-15 08:30AM  Special Report: The war on big food at Fortune
12:37AM  [$$] Criminal Cases Roil Food Industry at The Wall Street Journal
May-20-15 08:20PM  Criminal Cases Roil Food Industry at The Wall Street Journal
03:50PM  ConAgra Unit to Pay Record Fine in Salmonella Case at The Wall Street Journal
03:50PM  ConAgra to pay $11.2M to settle salmonella criminal case
02:39PM  REUTERS BUSINESS NEWS SCHEDULE AT 1830 GMT/2:30 PM ET
01:57PM  ConAgra fined $11.2M for salmonella peanut butter at USA TODAY
01:10PM  ConAgra to pay $11.2 million to settle salmonella criminal case at Los Angeles Times
01:05PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
01:04PM  ConAgra pleads guilty, pays record fine tied to peanut butter recall Reuters
12:08PM  ConAgra enters guilty plea tied to 2007 peanut butter recall
12:08PM  ConAgra to pay $11.2M to settle criminal charge for shipping salmonella-tainted peanut butter
12:00PM  ConAgra Foods Announces Resolution Related to 2007 Voluntary Peanut Butter Recall Business Wire
May-19-15 10:16PM  US investigation of 2007 peanut butter recall wraps up
11:34AM  Chef Billy Parisi Takes on Summer Grilling, Offers Creative Twists to Cookout Favorites PR Newswire
May-18-15 01:25PM  Orville Redenbacher Added A Tastier Pop To Popcorn at Investor's Business Daily
May-15-15 09:31AM  The ?Organic? Game Is On at Fox Business
May-13-15 04:33PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial
01:40PM  ConAgra Boosts Frozen Foods Business with Blake's Buyout - Analyst Blog
12:26PM  Did Beyonc? and Jay-Z Kick Off a Vegan Craze? at Fox Business
May-12-15 05:32PM  ConAgra Buys Blake's All Natural Foods at The Wall Street Journal
04:30PM  ConAgra Foods Acquires Blakes All Natural Foods Business Wire
09:06AM  Is General Mills on Track to Turn Around?
May-11-15 12:10PM  Does It Make Sense to Add General Mills to Your Portfolio?
May-08-15 04:42PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Apr-29-15 06:14PM  Final Glance: Food companies
02:53PM  Midday Glance: Food companies
10:45AM  Early Glance: Food companies
Apr-22-15 01:00PM  This 'Recession-Proof' Stock Could Deliver 35% Gains
Apr-21-15 11:21AM  Facebook, McDonald's and Google ready reports, China developer defaults
Apr-20-15 04:33PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure
Apr-15-15 05:27PM  ConAgra Execs Serve Up $23M in Stock Sales at Barrons.com
Apr-14-15 06:07PM  Corvex Eliminates Position in ConAgra Foods in 4Q14
Apr-09-15 12:20PM  ConAgra shows how to use 'small data' wisely at bizjournals.com
Apr-06-15 12:19AM  Weekly CFO Sells Highlight: Northstar Realty Finance, Costco, ConAgra Foods
Apr-05-15 11:41PM  Weekly Insider Sells Highlight: TWTR, NRF, COST, CAG
Apr-03-15 01:04PM  CONAGRA FOODS INC /DE/ Financials
Apr-02-15 09:30PM  Is this the most interesting man in Denver economic development? (Video) at bizjournals.com
08:45AM  ConAgra Foods Announces Dividend Payment at noodls
08:30AM  ConAgra Foods Announces Dividend Payment Business Wire
08:03AM  Kids Set out to Make Their Mark on Child Hunger During National Service Month Business Wire
Mar-31-15 12:32PM  New Research Indicates Ounce for Ounce, Frozen Meals Provide the Same or Better Calorie and Nutrient Benefit Than Pricier Diet Programs Business Wire
Mar-30-15 07:06PM  The Stronger Dollar Affects US Growth, Down to 2.2% in 4Q14
12:24PM  CONAGRA FOODS INC /DE/ Files SEC form 10-Q, Quarterly Report
08:44AM  ConAgra Foods (CAG) in Focus: Stock Moves 5.8% Higher - Tale of the Tape
08:17AM  Analysts' Actions -- Altera, Nike, Oracle, Madison Square Garden and More TheStreet
Mar-27-15 09:04PM  Madison Square Garden, Manitowoc Lead Friday's After-Hours Movers +5.78%
08:48AM  Citadel Advisors Adds a New Position in ConAgra Foods
07:16AM  Highlights of Citadel Advisors 4Q14 Portfolio
Mar-26-15 05:35PM  Food Stocks To Watch: ConAgra Earnings Beat Q3 Estimates at Investor's Business Daily
04:58PM  Lululemon and Red Hat are big market movers
04:32PM  Red Hat tops S&P 500 after strong quarter at Financial Times
01:22PM  ConAgra Tops Earnings on Cost-Saving Plans, Revenues Rise - Analyst Blog
12:45PM  4 Stocks, 4 trades: LULU, CAG, WGO & UNP
11:06AM  Cramer - Worst May Be Behind ConAgra, but Processed Foods Are Out at TheStreet
11:02AM  Lululemon bounces back; SanDisk tumbles on outlook cut at MarketWatch
10:54AM  ConAgra shares off; private brands unit struggles at USA TODAY
09:45AM  ConAgra Reports Losses But Raises 2015 Outlook On Earnings Beat at TheStreet
09:35AM  ConAgra (CAG) Stock Gains Today on Earnings Beat at TheStreet
09:30AM  ConAgra Pleases With Earnings and Guidance, Even After Huge Charge at 24/7 Wall St.
09:27AM  Stocks to Watch: Lululemon, SanDisk, Accenture at The Wall Street Journal
09:22AM  Cramer's Mad Dash: CAG & UNP
09:21AM  ConAgra Foods Up On Earnings Beat, '15 Outlook at Investor's Business Daily
09:14AM  ConAgra (CAG) Tops Q3 Earnings, Barely Beats Revenues - Tale of the Tape
09:13AM  ConAgra 3Q hurt by charge; adjusted profit tops expectations
08:57AM  ConAgra reports better-than-expected profit, raises forecast
08:56AM  Morning Movers: Lululemon Lower on Guidance; ConAgra Jumps on Big Beat at Barrons.com
08:52AM  ConAgra Raises Earnings Outlook at The Wall Street Journal
08:26AM  ConAgra reports 3Q loss
07:59AM  Early movers: LULU, SNDK, CAG, WGO, MCD & more at CNBC
07:58AM  ConAgra Foods Comparable Third-Quarter EPS above Expectations; Fiscal 2015 EPS Guidance Increased; Fiscal 2015 Debt Reduction Goal Reaffirmed; Impairment Charge for Private Brands at noodls
07:53AM  ConAgra Foods stock gains after better-than-expected profit, upbeat outlook at MarketWatch
07:52AM  ConAgra reports quarterly loss, lower sales
07:37AM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fina
07:30AM  ConAgra Foods Comparable Third-Quarter EPS above Expectations; Fiscal 2015 EPS Guidance Increased; Fiscal 2015 Debt Reduction Goal Reaffirmed; Impairment Charge for Private Brands Business Wire
Mar-25-15 06:46PM  Biotechs could be the early warning for stocks at CNBC
03:46PM  Buy ConAgra for Its Expanding Product Line on the Expectation of Longer Term Profits at TheStreet
02:25PM  What to Watch in the Day Ahead - Thursday, March 26 Reuters
02:15PM  Kraft deal: Who's next?
12:05PM  Kraft's Long and Complicated Deal-Making History at The Wall Street Journal
11:23AM  ConAgra Foods (CAG) Stock Up Today Ahead of Earnings Results at TheStreet
08:08AM  ConAgra Foods to Report Earnings Under the Cloud of a Strong Dollar at TheStreet
Mar-24-15 09:20AM  Will ConAgra (CAG) Beat Q3 Earnings on Cost-Saving Efforts? - Analyst Blog
Mar-23-15 05:49AM  Watch for stock volatility this week at CNBC
Mar-22-15 05:00PM  Facebook and Greek debt what to watch for in the week ahead at Fortune
04:57PM  15 Upcoming Earnings Reports To Keep An Eye On
Mar-20-15 06:31PM  Watch for stock volatility next week at CNBC
03:52PM  What to Watch in the Week Ahead and on Monday, March 23 Reuters
Mar-19-15 06:00PM  Meet 4 Food And Beverage Stocks With Rising Dividends at Investor's Business Daily
10:15AM  ConAgra Foods Announces Details of Fiscal 2015 Third-Quarter Earnings Release and Conference Call at noodls
10:00AM  ConAgra Foods Announces Details of Fiscal 2015 Third-Quarter Earnings Release and Conference Call Business Wire
Mar-18-15 12:34PM  CORRECTING and REPLACING ConAgra Foods Conserves 97 Million Gallons of Water, Optimizes Packaging to Save 15 Million Pounds of Material, and Eliminates 58,700 Tons Waste Business Wire
Mar-17-15 11:08AM  ConAgra Foods St. Louis Employees Fight Child Hunger During Employee Month of Service Business Wire
11:04AM  Higher Interest Rates Not Toxic For All U.S. Stocks at Forbes
Mar-12-15 07:00PM  The food trade: 5 appetizing plays at CNBC
05:00PM  The food trade: 5 fast plays
10:10AM  Stock Market News for March 12, 2015 - Market News
ConAgra Foods, Inc. operates as a food company primarily in North America. The company operates through three segments: Consumer Foods, Commercial Foods, and Private Brands. The Consumer Foods segment provides branded food products in various categories, such as meals, entrees, condiments, sides, snacks, and desserts to various retail channels, such as grocery and convenience stores across frozen, refrigerated, and shelf-stable temperature classes. This segment's principal brands include Alexia, ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt's, Marie Callender's, Odom's Tennessee Pride, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's, and Wesson. The Commercial Foods segment offers food and ingredients primarily to commercial, foodservice, food manufacturing, and industrial customers. It provides frozen and sweet potato items, vegetable products, and spice and frozen bakery goods under the Lamb Weston, and Spicetec Flavors & Seasonings brand names. The Private Brands segment offers private branded and customized food items in various retail channels, including grocery and convenience stores. Its products consist of hot and ready-to-eat cereals; condiments; bars and coordinated categories; pastas; and retail bakery goods. ConAgra Foods, Inc. was founded in 1919 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ross Andrew GeorgeEVP and CSOApr 09Option Exercise24.7484,0002,078,16098,839Apr 13 04:36 PM
Ross Andrew GeorgeEVP and CSOApr 09Sale37.7564,7702,445,31434,069Apr 13 04:36 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 08Option Exercise24.7435,347874,485163,142Apr 09 04:29 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 08Sale37.9335,3471,340,733127,795Apr 09 04:29 PM
BAY MOGENS CDirectorApr 07Option Exercise22.6951,0001,157,430118,454Apr 09 06:04 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 07Option Exercise24.7448,6531,203,675176,448Apr 09 04:29 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyApr 07Sale38.0448,6531,850,570127,795Apr 09 04:29 PM
BAY MOGENS CDirectorApr 07Sale37.9630,4951,157,65187,959Apr 09 06:04 PM
Gehring JohnEVP and CFOApr 06Option Exercise23.93160,0003,828,800207,427Apr 07 04:37 PM
Gehring JohnEVP and CFOApr 06Sale37.96160,0006,074,35247,427Apr 07 04:37 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 02Option Exercise26.1530,000784,500130,943Apr 03 02:29 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 02Sale37.5030,0001,125,000100,943Apr 03 02:29 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerMar 31Option Exercise23.45220,0005,159,600268,562Apr 01 04:52 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerMar 31Sale36.73220,0008,080,88648,562Apr 01 04:52 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryMar 30Option Exercise23.9345,0001,076,850145,943Apr 01 04:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryMar 30Sale36.5645,0001,645,173100,943Apr 01 04:47 PM
Wise Robert GSVP, Corporate ControllerJan 17Option Exercise0.005,000015,617Jan 20 04:41 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 06Option Exercise24.7424,800613,55269,280Jan 07 04:33 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 06Sale35.2224,800873,45144,480Jan 07 04:33 PM
McGough Thomas MPresident, Consumer FoodsJan 05Option Exercise23.9011,236268,54060,388Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 05Option Exercise25.32190,0004,810,580253,060Jan 06 05:26 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryJan 05Option Exercise23.9315,000358,950115,943Jan 07 04:32 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 05Option Exercise24.7411,200277,08855,680Jan 07 04:33 PM
Theophilus Nicole BEVP, Chief HR OfficerJan 05Sale35.6111,200398,82944,480Jan 07 04:33 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryJan 05Sale35.6015,000534,024100,943Jan 07 04:32 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 05Sale35.66190,0006,775,30563,060Jan 06 05:26 PM
McGough Thomas MPresident, Consumer FoodsJan 05Sale35.948,779315,50051,609Jan 06 05:21 PM
McGough Thomas MPresident, Consumer FoodsJan 02Option Exercise19.5911,264220,71057,052Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 02Option Exercise22.90202,0004,626,300265,060Jan 06 05:26 PM
McGough Thomas MPresident, Consumer FoodsJan 02Sale36.157,900285,54849,152Jan 06 05:21 PM
Maass Paul TPres-Private Brnds & Comml FdsJan 02Sale36.03202,0007,278,34363,060Jan 06 05:26 PM
Wise Robert GSVP, Corporate ControllerDec 23Option Exercise23.906,600157,74017,217Dec 23 04:28 PM
Wise Robert GSVP, Corporate ControllerDec 23Sale36.906,600243,54510,617Dec 23 04:28 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyDec 22Option Exercise24.80198,0004,911,300303,795Dec 23 04:21 PM
Gehring JohnEVP and CFODec 22Option Exercise21.10160,0003,375,200207,427Dec 23 04:25 PM
Gehring JohnEVP and CFODec 22Sale36.82160,0005,891,52047,427Dec 23 04:25 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyDec 22Sale36.58176,0006,438,925127,795Dec 23 04:21 PM
McGough Thomas MPresident, Consumer FoodsNov 28Option Exercise19.055,00095,25049,197Dec 02 04:28 PM
McGough Thomas MPresident, Consumer FoodsNov 28Sale36.003,409122,72445,788Dec 02 04:28 PM
McGough Thomas MPresident, Consumer FoodsNov 18Option Exercise19.055,00095,25047,657Nov 20 04:50 PM
McGough Thomas MPresident, Consumer FoodsNov 18Sale35.003,460121,10044,197Nov 20 04:50 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerSep 24Option Exercise21.26120,0002,551,200168,562Sep 26 04:29 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerSep 24Sale33.44120,0004,013,24448,562Sep 26 04:29 PM
McGough Thomas MPresident, Consumer FoodsSep 23Option Exercise21.266,900146,69447,898Sep 24 05:20 PM
McGough Thomas MPresident, Consumer FoodsSep 23Sale33.135,241173,63442,657Sep 24 05:20 PM
McGough Thomas MPresident, Consumer FoodsSep 22Option Exercise21.263,10065,90640,998Sep 24 05:20 PM
STINSON KENNETH EDirectorJul 14Option Exercise25.779,000231,93095,465Jul 16 05:48 PM
Theophilus Nicole BEVP, Chief HR OfficerJul 14Option Exercise24.7428,000692,72061,918Jul 16 05:49 PM
Theophilus Nicole BEVP, Chief HR OfficerJul 14Sale30.6328,000857,66533,918Jul 16 05:49 PM
STINSON KENNETH EDirectorJul 14Sale30.587,591232,13487,874Jul 16 05:48 PM
Wise Robert GSVP, Corporate ControllerJul 11Option Exercise0.005,000012,229Jul 15 04:32 PM
JURGENSEN WILLIAM GDirectorJul 09Option Exercise25.779,000231,93098,907Jul 11 04:26 PM
JURGENSEN WILLIAM GDirectorJul 09Sale30.647,581232,28291,326Jul 11 04:26 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise25.779,000231,93065,787Jul 09 05:07 PM
BUTLER STEPHEN GDirectorJul 07Sale30.999,000278,91056,787Jul 09 05:07 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyJul 03Option Exercise26.1542,0001,098,300133,705Jul 08 05:10 PM
McGough Thomas MPresident, Consumer FoodsJul 03Option Exercise21.2610,000212,60032,851Jul 08 05:13 PM
McGough Thomas MPresident, Consumer FoodsJul 03Sale31.073,937122,32328,914Jul 08 05:13 PM
Batcheler ColleenEVP Gen Counsel & Corp SectyJul 03Sale31.0242,0001,302,84891,705Jul 08 05:10 PM
Bolles Albert D.EVP & Chief Tech & Op OfficerJul 02Sale30.3680024,2880Jul 07 04:36 PM
BAY MOGENS CDirectorJul 01Option Exercise25.779,000231,93075,281Jul 03 05:02 PM
BAY MOGENS CDirectorJul 01Sale29.677,827232,22267,454Jul 03 05:02 PM
RODKIN GARY MPresident and CEOJun 30Option Exercise26.8050,0001,340,000689,765Jul 01 07:05 PM
RODKIN GARY MPresident and CEOJun 30Sale29.3550,0001,467,360639,765Jul 01 07:05 PM
RODKIN GARY MPresident and CEOJun 23Option Exercise26.8050,0001,340,000689,765Jun 24 04:19 PM
RODKIN GARY MPresident and CEOJun 23Sale28.8450,0001,441,980639,765Jun 24 04:19 PM
RODKIN GARY MPresident and CEOJun 16Option Exercise26.8050,0001,340,000689,765Jun 17 04:40 PM
RODKIN GARY MPresident and CEOJun 16Sale32.4450,0001,622,000639,765Jun 17 04:40 PM
RODKIN GARY MPresident and CEOJun 09Option Exercise26.8050,0001,340,000689,765Jun 10 08:28 PM
RODKIN GARY MPresident and CEOJun 09Sale32.6550,0001,632,350639,765Jun 10 08:28 PM
RODKIN GARY MPresident and CEOJun 02Option Exercise26.8050,0001,340,000689,765Jun 03 04:36 PM
RODKIN GARY MPresident and CEOJun 02Sale32.1950,0001,609,295639,765Jun 03 04:36 PM
RODKIN GARY MPresident and CEOMay 27Option Exercise26.8050,0001,340,000689,765May 29 06:10 PM
RODKIN GARY MPresident and CEOMay 27Sale31.5750,0001,578,365639,765May 29 06:10 PM
GILD [NASD]
Gilead Sciences Inc.
IndexS&P 500 P/E12.69 EPS (ttm)8.80 Insider Own0.50% Shs Outstand1.47B Perf Week2.20%
Market Cap164.17B Forward P/E10.13 EPS next Y11.02 Insider Trans-18.42% Shs Float1.46B Perf Month6.18%
Income14.21B PEG0.95 EPS next Q2.66 Inst Own85.60% Short Float3.80% Perf Quarter6.89%
Sales27.49B P/S5.97 EPS this Y306.10% Inst Trans-1.84% Short Ratio5.18 Perf Half Y9.16%
Book/sh11.55 P/B9.67 EPS next Y1.56% ROA42.70% Target Price121.22 Perf Year34.75%
Cash/sh7.69 P/C14.54 EPS next 5Y13.30% ROE91.30% 52W Range78.50 - 116.83 Perf YTD18.51%
Dividend1.72 P/FCF9.99 EPS past 5Y39.10% ROI44.80% 52W High-4.38% Beta0.75
Dividend %1.54% Quick Ratio2.40 Sales past 5Y28.80% Gross Margin86.00% 52W Low42.31% ATR2.32
Employees7000 Current Ratio2.70 Sales Q/Q51.90% Oper. Margin64.00% RSI (14)69.02 Volatility1.80% 2.16%
OptionableYes Debt/Eq0.72 EPS Q/Q107.50% Profit Margin51.70% Rel Volume1.13 Prev Close111.22
ShortableYes LT Debt/Eq0.69 EarningsApr 30 AMC Payout4.60% Avg Volume10.71M Price111.71
Recom1.90 SMA205.76% SMA508.58% SMA2008.56% Volume12,075,190 Change0.44%
May-01-15Reiterated RBC Capital Mkts Outperform $118 → $120
May-01-15Reiterated Piper Jaffray Overweight $116 → $120
Feb-04-15Reiterated RBC Capital Mkts Outperform $125 → $118
Dec-23-14Reiterated Deutsche Bank Buy $142 → $125
Dec-09-14Reiterated Argus Buy $110 → $130
Oct-29-14Reiterated RBC Capital Mkts Outperform $115 → $125
Oct-13-14Reiterated FBR Capital Outperform $125 → $130
Sep-25-14Reiterated Needham Buy $95 → $120
Aug-22-14Reiterated RBC Capital Mkts Outperform $102 → $115
Aug-15-14Initiated FBR Capital Outperform $125
Aug-11-14Reiterated Argus Buy $90 → $110
Jul-28-14Reiterated Maxim Group Buy $112 → $127
Jul-24-14Reiterated RBC Capital Mkts Outperform $96 → $102
Apr-28-14Reiterated Maxim Group Buy $101 → $112
Feb-21-14Reiterated Barclays Overweight $90 → $95
Feb-10-14Reiterated Argus Buy $84 → $90
Feb-05-14Reiterated RBC Capital Mkts Outperform $90 → $96
Feb-05-14Reiterated Needham Buy $85 → $95
Feb-05-14Reiterated Maxim Group Buy $98 → $101
Feb-04-14Upgrade Robert W. Baird Neutral → Outperform $65 → $103
May-25-15 02:00PM  Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog
01:01AM  FireEye, Gilead Sciences, and Aeropostale: Doug Kass' Views
May-24-15 09:15AM  Large Companies With Fastest Revenue and Earnings Growth in 2015 at 24/7 Wall St.
May-23-15 10:00AM  Can Gilead keep growing without a big deal? at Fortune
09:30AM  The Most Loved Biotechs of Big Hedge Funds at 24/7 Wall St.
06:32AM  The best blue chips to own forever at USA TODAY
May-22-15 09:02PM  Will This Drug Beat Gilead to Market in NASH? at Investopedia
04:40PM  Medical cost inflation hits 8-year high, but why? at CNBC
11:30AM  Kite Pharma Starts Dosing in Phase I/II Study on KTE-C19 - Analyst Blog
11:21AM  Gilead Sciences: Hep-C Prescriptions Continue to Fall at Barrons.com
08:49AM  Should You Get Rid of CytRx Corporation (CYTR) Now? - Tale of the Tape
08:11AM  Who are Gilead Sciences' (GILD) main competitors? at Investopedia
May-21-15 03:50PM  J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog
02:18PM  Why Do Biotech Stocks Look Attractive?
08:27AM  What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?
May-20-15 04:22PM  Will the J&J Deal With Achillion Transform the Hep C Market? at The Wall Street Journal
02:50PM  Top 10 stocks of the David Letterman era
01:52PM  Achillion Dives As J&J Hep C Deal Chills Buyout Buzz at Investor's Business Daily
12:44PM  Gilead Sciences Inc. (GILD), Yahoo! Inc. (YHOO) and Sinclair Broadcast Group Inc. (SBGI) Among the Top Picks of Bernard Selz at Insider Monkey
12:17PM  Gilead patents on costly hepatitis C drug challenged in 5 countries
12:00PM  Soaring Cash Makes Gilead Cheaper Than You Think at Investopedia
11:44AM  UPDATE 1-Achillion partners with J&J to develop hep C drugs (May 19)
10:50AM  High Price for Gilead Sciences Hep C Drug Prompts Patent Challenges at The Wall Street Journal
09:46AM  Gilead Sciences: Little Risk From Achillion's Hep-C Partnership With J&J at Barrons.com
09:34AM  Move Over Chip Stocks: Here Are 5 Top Biotechs at Investor's Business Daily
09:08AM  10 S&P 500 Companies to Have the Biggest Profit Growth in 2015 at TheStreet
08:45AM  Intercept Pharmaceuticals (ICPT) in Focus: Stock Tanks 16.1% - Tale of the Tape
May-19-15 05:34PM  Momentum bargain stocks: TSLA & more
05:07PM  Achillion, J&J To Jointly Develop Hepatitis C Drugs at Investor's Business Daily
04:51PM  Healthcare Winners and Losers: May 19, 2015
02:00PM  Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog
01:50PM  Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog
09:34AM  Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon at TheStreet
08:39AM  Eleven Biotherapeutics (EBIO) in Focus: Stock Tanks 69.2% - Tale of the Tape
08:33AM  3 Best Biotech Stocks to Add to Your Portfolio at TheStreet
06:28AM  Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest at TheStreet
May-18-15 06:44PM  5 Things Gilead Sciences Wants You to Know at Investopedia
05:00PM  Gilead Sciences to Present at the UBS 2015 Global Healthcare Conference on Tuesday, May 19 Business Wire
01:29PM  Jim Cramer -- St. Jude, Home Depot Lead Stocks in Second-Strongest Sectors at TheStreet
12:32PM  15 Years Later: A Look At The Nasdaq Composite Then and Now at Forbes
08:42AM  Gilead Sciences (GILD) Stock: 3 Reasons Why It Is a Top Choice for Growth Investors - Tale of the Tape
08:03AM  Is the Stock Market Due for a Correction?
07:39AM  How to play weak Q2 earnings season: Analysts at CNBC
May-15-15 06:13PM  Health Care Sector Delivers Healthy Q1 Results at Investor's Business Daily
03:35PM  Agenus (AGEN) Provides Update on its Brain Cancer Vaccine - Analyst Blog
01:40PM  Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog
01:04PM  GILEAD SCIENCES INC Financials
12:25PM  Dalio's Bridgewater Dramatically Adds to Apple, Cuts Gilead at Barrons.com
11:34AM  Gilead: Hep-C Prescriptions Fall, But Quarter Tracking Higher at Barrons.com
11:26AM  Prestige Brands Holdings Beats on Q4 Earnings, Revenues - Analyst Blog
May-14-15 02:07PM  Biotech: Asco Giveth, Asco Taketh Away at Barrons.com
01:52PM  What the travails of the UK's largest grocer can teach the pharmaceutical industry at Forbes
07:00AM  Biotech Fans Could Have a Hangover at Morningstar
12:37AM  Vertex Could Give Investors Vertigo at The Wall Street Journal
May-13-15 02:55PM  Retail Sector in the Spotlight - Earnings Trends
02:55PM  Retail Sector in the Spotlight - Earnings Outlook
02:40PM  Gilead: No Big Deals at Barrons.com
01:52PM  How much do Americans spend on drugs?
12:40PM  Vertex Pharmaceuticals' Orkambi Wins FDA Panel Backing - Analyst Blog
10:56AM  Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog
10:52AM  Vertex Could Give Investors Vertigo at The Wall Street Journal
09:53AM  Gilead Sciences: Hep-C Prcing in Japan Better Than Expected at Barrons.com
09:47AM  Gilead Sciences, Inc. (GILD), Infoblox Inc (BLOX) Among David Lamonds Top Healthcare and Technology Stock Picks at Insider Monkey
12:01AM  500,000 Americans spend $50K on medicine each year at CNBC
12:00AM  Drug Costs Top $50K A Year For Half Million Americans at Forbes
May-12-15 06:34PM  Sanders Asks VA to Break Patents on Gilead and AbbVie Hep C Drugs at The Wall Street Journal
06:34PM  The Most Important Number for Gilead Shareholders at Investopedia
05:44PM  FDA panel approves Vertex drug
05:00PM  Gilead Sciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13 Business Wire
09:46AM  TrovaGene (TROV) in Focus: Stock Rises 7.1% - Tale of the Tape
09:20AM  Inovio Narrows Q1 Loss Y/Y, Misses Earnings Estimates - Analyst Blog
08:05AM  Short Sellers Start to Get Nervous on Biotech at 24/7 Wall St.
May-11-15 12:39PM  Gilead Leads HCV Race Despite Competition From AbbVie
12:22PM  ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary
10:10AM  Osiris Therapeutics Q1 Earnings & Revenues Grow Y/Y - Analyst Blog
09:26AM  Bio-Techne Lags on Q3 Earnings, Revenues; Expenses Rise - Analyst Blog
09:11AM  Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape
May-10-15 08:11PM  10-Q for Gilead Sciences, Inc. at Company Spotlight
11:00AM  These biotech names are ripe for mergers: Analysts at CNBC
May-09-15 10:49AM  The Best And Worst ETFs Of The Week Amid Biotech Rebound
May-08-15 02:53PM  GILEAD SCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
01:00PM  Corcept Therapeutics Reports Wider Q1 Loss, Revenue Miss - Analyst Blog
12:56PM  Gilead Sciences: How Are Hepatitis C Prescriptions Holding Up? at Barrons.com
11:50AM  Alnylam's Q1 Loss Narrower than Expected, Confirms Guidance - Analyst Blog
09:30AM  Zacks Earnings Trends Highlights: Walgreen Boots, Amazon and Gilead Sciences - Press Releases
06:16AM  WHO adds hepatitis C drugs to essential list, urges lower prices
May-07-15 02:49PM  Standout Sectors of Q1 Earnings Season - Earnings Trends
01:55PM  Sucampo Posts In-Line First-Quarter Earnings, Revenue Miss - Analyst Blog
May-06-15 05:55PM  Gilead Sciences Execs Sell $19 Million in Stock at Barrons.com
02:40PM  Synageva BioPharma: Another Winning Lottery Ticket For Investors at Forbes
09:30AM  Gilead's John C. Martin: One Breakthrough Drug After Another at Forbes
09:03AM  Gilead to Buy EpiTherapeutics for $65 Million at The Wall Street Journal
08:49AM  Gilead Sciences Acquires EpiTherapeutics at noodls
08:30AM  Gilead Sciences Acquires EpiTherapeutics Business Wire
06:12AM  Global 2000: Hall Of Fame CEOs On Growth, Good Advice And The Next Decade at Forbes
May-05-15 05:28PM  Gilead's Price Cuts Cause Hep C Scripts to Soar at Investopedia
01:16PM  Healthcare Mid-Day Winners and Losers: May 05, 2015
12:51PM  Healthcare AM Winners and Losers: May 05, 2015
12:46PM  Healthcare AM Winners and Losers: May 04, 2015
12:46PM  Healthcare Mid-Day Winners and Losers: May 04, 2015
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. The company's products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver disease. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with Bristol-Myers Squibb Company', Janssen R&D Ireland, and Japan Tobacco Inc. to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carter Paul RutherfordEVP Commercial OpsMay 15Option Exercise67.786,000406,68753,632May 19 07:24 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMay 15Option Exercise21.3470,0001,493,550235,168May 19 07:25 PM
Alton Gregg HEVP, Corp & Med AffairsMay 15Option Exercise19.2025,000479,947168,422May 19 07:25 PM
Carter Paul RutherfordEVP Commercial OpsMay 15Sale110.006,000660,02047,632May 19 07:24 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOMay 15Sale109.4570,0007,661,533165,168May 19 07:25 PM
Alton Gregg HEVP, Corp & Med AffairsMay 15Sale110.0125,0002,750,210143,422May 19 07:25 PM
Carter Paul RutherfordEVP Commercial OpsMay 10Option Exercise0.005,000050,439May 12 06:02 PM
MILLIGAN JOHN FPresident and COOMay 07Option Exercise14.50100,0001,450,2501,129,108May 11 08:24 PM
MILLIGAN JOHN FPresident and COOMay 07Sale101.00100,00010,100,1621,029,108May 11 08:24 PM
Whitley Richard JamesDirectorMay 05Option Exercise19.6321,720426,36437,361May 07 05:14 PM
Carter Paul RutherfordEVP Commercial OpsMay 01Option Exercise80.652,000161,30047,439May 05 04:23 PM
MARTIN JOHN CChairman and CEOMay 01Option Exercise14.50150,0002,175,3754,405,876May 05 05:47 PM
Washington Robin LEVP, CFOMay 01Option Exercise29.7016,842500,13044,566May 05 07:38 PM
Alton Gregg HEVP, Corp & Med AffairsMay 01Option Exercise19.0910,000190,850155,422May 05 07:38 PM
Washington Robin LEVP, CFOMay 01Sale105.0616,8421,769,40527,724May 05 07:38 PM
MARTIN JOHN CChairman and CEOMay 01Sale104.95150,00015,742,4914,255,876May 05 05:47 PM
Carter Paul RutherfordEVP Commercial OpsMay 01Sale103.182,000206,36545,439May 05 04:23 PM
Alton Gregg HEVP, Corp & Med AffairsMay 01Sale104.0712,0001,248,871143,422May 05 07:38 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOApr 15Option Exercise20.7470,0001,451,800235,168Apr 17 02:23 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOApr 15Sale103.8470,0007,268,627165,168Apr 17 02:23 PM
Alton Gregg HEVP, Corp & Med AffairsApr 08Option Exercise19.095,00095,425150,422Apr 09 04:40 PM
Carter Paul RutherfordEVP Commercial OpsApr 08Option Exercise80.651,00080,65046,439Apr 09 04:40 PM
Alton Gregg HEVP, Corp & Med AffairsApr 08Sale100.005,000500,000145,422Apr 09 04:40 PM
Carter Paul RutherfordEVP Commercial OpsApr 08Sale100.001,000100,00045,439Apr 09 04:40 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise80.651,00080,65046,439Apr 03 05:24 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Option Exercise19.095,00095,425152,422Apr 03 05:24 PM
MARTIN JOHN CChairman and CEOApr 01Option Exercise14.50150,0002,175,3754,405,876Apr 03 05:24 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale96.537,000675,715145,422Apr 03 05:24 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale98.041,00098,04445,439Apr 03 05:24 PM
MARTIN JOHN CChairman and CEOApr 01Sale96.74150,00014,511,4634,255,876Apr 03 05:24 PM
Whitley Richard JamesDirectorMar 02Option Exercise26.995,000134,95020,641Mar 03 04:12 PM
Alton Gregg HEVP, Corp & Med AffairsMar 02Option Exercise19.0910,000190,850159,422Mar 04 07:49 PM
MARTIN JOHN CChairman and CEOMar 02Option Exercise14.50150,0002,175,3754,405,876Mar 04 07:48 PM
Carter Paul RutherfordEVP Commercial OpsMar 02Option Exercise80.652,000161,30047,439Mar 04 07:49 PM
MARTIN JOHN CChairman and CEOMar 02Sale103.51150,00015,526,2454,255,876Mar 04 07:48 PM
Alton Gregg HEVP, Corp & Med AffairsMar 02Sale103.6312,0001,243,615147,422Mar 04 07:49 PM
Carter Paul RutherfordEVP Commercial OpsMar 02Sale104.182,000208,36445,439Mar 04 07:49 PM
Whitley Richard JamesDirectorMar 02Sale103.435,000517,13615,641Mar 03 04:12 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 17Option Exercise16.4070,0001,147,650235,168Feb 19 06:42 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOFeb 17Sale103.0170,0007,210,740165,168Feb 19 06:42 PM
WOLD OLSEN PERDirectorFeb 06Buy99.9210,000999,15088,173Feb 10 04:30 PM
MARTIN JOHN CChairman and CEOFeb 02Option Exercise14.50150,0002,175,3754,272,987Feb 04 08:15 PM
Washington Robin LEVP, CFOFeb 02Option Exercise25.1433,192834,58683,024Feb 04 08:52 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 02Option Exercise19.0910,000190,850123,694Feb 04 08:51 PM
Carter Paul RutherfordEVP Commercial OpsFeb 02Option Exercise80.652,000161,30036,308Feb 04 08:52 PM
Whitley Richard JamesDirectorFeb 02Option Exercise26.995,000134,95020,641Feb 04 04:04 PM
MARTIN JOHN CChairman and CEOFeb 02Sale105.43150,00015,815,2494,122,987Feb 04 08:15 PM
Washington Robin LEVP, CFOFeb 02Sale105.3833,1923,497,66249,832Feb 04 08:52 PM
Alton Gregg HEVP, Corp & Med AffairsFeb 02Sale105.7312,0001,268,719111,694Feb 04 08:51 PM
Carter Paul RutherfordEVP Commercial OpsFeb 02Sale106.152,000212,31034,308Feb 04 08:52 PM
Whitley Richard JamesDirectorFeb 02Sale105.675,000528,35815,641Feb 04 04:04 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 15Option Exercise16.4070,0001,147,650189,302Jan 20 12:46 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOJan 15Sale98.4770,0006,893,083119,302Jan 20 12:46 PM
Carter Paul RutherfordEVP Commercial OpsJan 08Option Exercise36.721,00036,72035,308Jan 12 03:55 PM
Carter Paul RutherfordEVP Commercial OpsJan 08Sale100.881,000100,88134,308Jan 12 03:55 PM
MARTIN JOHN CChairman and CEOJan 05Sale96.651009,6654,122,987Jan 06 04:20 PM
Whitley Richard JamesDirectorJan 02Option Exercise26.995,000134,95020,641Jan 06 02:12 PM
Carter Paul RutherfordEVP Commercial OpsJan 02Option Exercise40.561,00040,56035,308Jan 06 04:21 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Option Exercise19.095,00095,425120,694Jan 06 04:20 PM
MARTIN JOHN CChairman and CEOJan 02Option Exercise14.50150,0002,175,3754,272,987Jan 06 04:20 PM
MARTIN JOHN CChairman and CEOJan 02Sale95.11149,90014,257,7224,123,087Jan 06 04:20 PM
Alton Gregg HEVP, Corp & Med AffairsJan 02Sale95.177,000666,192113,694Jan 06 04:20 PM
Whitley Richard JamesDirectorJan 02Sale95.225,000476,10015,641Jan 06 02:12 PM
Carter Paul RutherfordEVP Commercial OpsJan 02Sale95.051,00095,05034,308Jan 06 04:21 PM
Cogan John FrancisDirectorDec 22Option Exercise14.3426,000372,77568,405Dec 24 12:58 PM
Cogan John FrancisDirectorDec 22Sale95.0326,0002,470,75542,405Dec 24 12:58 PM
MILLIGAN JOHN FPresident and COODec 08Option Exercise8.01146,8231,175,3181,120,871Dec 10 05:32 PM
MILLIGAN JOHN FPresident and COODec 08Sale106.26146,82315,601,122974,048Dec 10 05:32 PM
MARTIN JOHN CChairman and CEODec 01Option Exercise8.01140,6331,125,7674,263,620Dec 03 07:13 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Option Exercise40.562,00081,12036,308Dec 03 07:14 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Option Exercise24.2931,000752,947149,694Dec 03 07:13 PM
Whitley Richard JamesDirectorDec 01Option Exercise26.995,000134,95020,641Dec 03 03:46 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Sale100.022,000200,03134,308Dec 03 07:14 PM
MARTIN JOHN CChairman and CEODec 01Sale100.72140,63314,164,8294,122,987Dec 03 07:13 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Sale100.7933,0003,325,922116,694Dec 03 07:13 PM
Whitley Richard JamesDirectorDec 01Sale100.195,000500,96915,641Dec 03 03:46 PM
Cogan John FrancisDirectorNov 21Option Exercise14.3425,000358,43867,405Nov 25 04:10 PM
Cogan John FrancisDirectorNov 21Sale101.2325,0002,530,77042,405Nov 25 04:10 PM
MILLIGAN JOHN FPresident and COONov 07Option Exercise8.01146,8951,175,8941,120,943Nov 12 12:48 PM
MILLIGAN JOHN FPresident and COONov 07Sale107.37146,89515,772,736974,048Nov 12 12:48 PM
Washington Robin LEVP, CFONov 05Option Exercise0.006,000055,832Nov 07 01:20 PM
Carter Paul RutherfordEVP Commercial OpsNov 04Option Exercise0.004,800037,044Nov 05 05:37 PM
Whitley Richard JamesDirectorNov 03Option Exercise26.995,000134,95020,641Nov 05 12:23 PM
MARTIN JOHN CChairman and CEONov 03Option Exercise8.01140,6251,125,7034,570,012Nov 05 02:05 PM
Carter Paul RutherfordEVP Commercial OpsNov 03Option Exercise40.563,000121,68035,244Nov 05 05:37 PM
Washington Robin LEVP, CFONov 03Option Exercise25.1433,192834,58683,024Nov 05 08:06 PM
Carter Paul RutherfordEVP Commercial OpsNov 03Sale112.463,000337,38032,244Nov 05 05:37 PM
MARTIN JOHN CChairman and CEONov 03Sale110.40140,62515,525,1024,429,387Nov 05 02:05 PM
Whitley Richard JamesDirectorNov 03Sale112.025,000560,09015,641Nov 05 12:23 PM
Washington Robin LEVP, CFONov 03Sale110.2633,1923,659,83749,832Nov 05 08:06 PM
Carter Paul RutherfordEVP Commercial OpsOct 24Option Exercise40.562,00081,12034,244Oct 28 01:35 PM
Carter Paul RutherfordEVP Commercial OpsOct 24Sale110.002,000220,00732,244Oct 28 01:35 PM
Cogan John FrancisDirectorOct 21Option Exercise14.3415,000215,06357,405Oct 23 01:54 PM
Cogan John FrancisDirectorOct 21Sale104.0815,0001,561,14942,405Oct 23 01:54 PM
MILLIGAN JOHN FPresident and COOOct 07Option Exercise8.01146,8951,175,8941,120,943Oct 09 02:10 PM
MILLIGAN JOHN FPresident and COOOct 07Sale104.60146,89515,365,818974,048Oct 09 02:10 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Option Exercise23.7631,000736,405153,694Oct 03 02:53 PM
MARTIN JOHN CChairman and CEOOct 01Option Exercise8.01140,6251,125,7034,570,012Oct 03 02:57 PM
MARTIN JOHN CChairman and CEOOct 01Sale105.91140,62514,893,8454,429,387Oct 03 02:57 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Sale105.9833,0003,497,259120,694Oct 03 02:53 PM
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E30.40 EPS (ttm)2.29 Insider Own0.10% Shs Outstand2.45B Perf Week0.07%
Market Cap170.35B Forward P/E23.43 EPS next Y2.97 Insider Trans-0.66% Shs Float2.31B Perf Month2.99%
Income5.54B PEG1.68 EPS next Q0.59 Inst Own92.70% Short Float2.35% Perf Quarter2.18%
Sales13.18B P/S12.93 EPS this Y13.20% Inst Trans-1.25% Short Ratio6.21 Perf Half Y11.85%
Book/sh12.67 P/B5.49 EPS next Y15.33% ROA14.40% Target Price74.40 Perf Year34.00%
Cash/sh2.32 P/C29.97 EPS next 5Y18.08% ROE20.00% 52W Range48.53 - 70.69 Perf YTD6.59%
Dividend0.48 P/FCF35.15 EPS past 5Y25.20% ROI19.70% 52W High-1.51% Beta0.63
Dividend %0.69% Quick Ratio1.90 Sales past 5Y12.90% Gross Margin- 52W Low43.46% ATR1.17
Employees9500 Current Ratio1.90 Sales Q/Q-46.00% Oper. Margin64.90% RSI (14)62.11 Volatility1.05% 1.77%
OptionableYes Debt/Eq0.00 EPS Q/Q-42.90% Profit Margin42.00% Rel Volume0.51 Prev Close69.37
ShortableYes LT Debt/Eq0.00 EarningsApr 30 AMC Payout19.20% Avg Volume8.76M Price69.62
Recom1.90 SMA202.57% SMA504.29% SMA20012.82% Volume4,506,984 Change0.36%
May-20-15Initiated Credit Agricole Outperform $77
Jan-30-15Reiterated Stifel Buy $280 → $308
Jan-30-15Reiterated Argus Buy $295 → $300
Jan-30-15Downgrade FBR Capital Outperform → Mkt Perform $260
Jan-23-15Reiterated Oppenheimer Outperform $250 → $290
Dec-08-14Reiterated Argus Buy $260 → $295
Nov-12-14Initiated Topeka Capital Markets Hold $261
Oct-31-14Upgrade Argus Hold → Buy $260
Oct-30-14Upgrade FBR Capital Mkt Perform → Outperform $250 → $260
Oct-30-14Reiterated Stifel Buy $281 → $280
Oct-24-14Reiterated Oppenheimer Outperform $270 → $250
Apr-25-14Reiterated RBC Capital Mkts Outperform $263 → $250
Apr-14-14Upgrade Robert W. Baird Neutral → Outperform $245
Apr-14-14Initiated Pacific Crest Outperform $241
Jan-31-14Reiterated FBR Capital Mkt Perform $210 → $250
Jan-21-14Reiterated Stifel Buy $255 → $292
Jan-16-14Reiterated Barclays Overweight $240 → $270
Oct-31-13Reiterated FBR Capital Mkt Perform $190 → $210
Oct-28-13Reiterated Barclays Overweight $215 → $240
Aug-02-13Reiterated Stifel Buy $217
May-24-15 04:37PM  Playing The Payment Processor Space? Here's One Strategy To Use
May-22-15 09:53AM  Laurentian Bank Honoured by VISA CNW Group
09:33AM  What is the Future for Target Stores? at Forbes
May-21-15 06:00PM  Cramer: Why you need to avoid Chinese stocks
11:00AM  FIDO Alliance Unveils Certification Testing Program for 1.0 Specification and Introduces 31 FIDO Certified(TM) Products Marketwired
May-20-15 02:50PM  Top 10 stocks of the David Letterman era
01:10PM  Soccer-FIFA sponsors Visa express "grave concern" over Qatar workers
12:05PM  Even Visa thinks the World Cup is a mess at Fortune
11:37AM  World Cup Sponsor Visa Presses FIFA on Qatar Worker Conditions at Bloomberg
07:08AM  Coverage initiated on Visa by Credit Agricole
May-19-15 05:09PM  MasterCard's Current Price Makes It Riskier for New Investors at TheStreet
10:01AM  Visa Checkout Announces Enrolled Customer Conversion Rate of Nearly 70 Percent* Business Wire
09:05AM  Morgan Stanley's 5 Financial Stocks To Buy for the Long Term at TheStreet
May-18-15 05:16PM  Berkshire Hathaway Cuts Stakes in Charter Communications, Viacom at The Wall Street Journal
12:37PM  US Budget Surplus for April Is Highest in Seven Years
09:30AM  The Zacks Analyst Blog Highlights: du Pont, Cisco Systems, Verizon Communications, AOL and Visa - Press Releases
May-17-15 04:17PM  Weekly 52-Week Highs Highlight: V, DLPH, FISV, NWL
May-15-15 05:03PM  13F Season: A Look At Warren Buffett's Q1 Moves
04:18PM  Dow 30 Stock Roundup: Cisco Earnings In Line, Verizon to Buy AOL - Analyst Blog
04:00PM  S&P 500 sets record despite weak data; Netflix leaps 4.5% at CNBC
08:20AM  How to avoid annoying airline fees at CNBC
May-14-15 07:00PM  Cramer: One of the strongest stocks in the game
05:49PM  American Express's Main Competition at Investopedia
01:40PM  Apple Inc. (AAPL) and Visa Inc (V) Among Top Bets of Madison Street Partners at Insider Monkey
May-12-15 05:56PM  Blackhawk Wins In Gift Cards; E-Cards Next? at Investor's Business Daily
01:31PM  'Disruptor' DocuSign raises $233 million at CNBC
09:44AM  Can Visa Buy Its Way To Growth With A Potential Acquisition Of Visa Europe?
May-11-15 05:30PM  American Express May Yet Win The Credit Card Class Wars at Forbes
04:15PM  Visa Europe to Exercise Option to Merge with Visa for $20B? - Analyst Blog
09:35AM  Dow Spring Flowers Include UnitedHealth, Visa And Three Others at Forbes
09:30AM  The Zacks Analyst Blog Highlights: Automatic Data Processing, Walt Disney, Visa, Chevron and DuPont - Press Releases
07:00AM  Morgan Stanley Still Likes Visa After Meeting With Management
May-08-15 06:06PM  Visa in talks to buy former Europe unit at Financial Times
05:30PM  US stocks jump the most since March following hiring gains
04:41PM  Dow 30 Stock Roundup: Disney, Visa Beat, Chevron Reports Mixed Results - Analyst Blog
04:40PM  Visa (V) Stock Closed Up on Possible Acquisition of Visa Europe at TheStreet
04:21PM  Visa in Talks to Buy Visa Europe for Up to $20 Billion
04:17PM  Visa Negotiating To Buy Visa Europe For $20 Billion at Investor's Business Daily
03:55PM  Visa in talks to buy former subsidiary Visa Europe for up to $20 billion: Bloomberg
03:28PM  Stocks advance on US jobs report, UK election results AP
03:22PM  Visa shares jump on acquisition report at CNBC
02:40PM  Visa Said in Talks to Buy Visa Europe for as Much as $20 Billion at Bloomberg
12:30PM  AP Exclusive: Chinese banks a haven for web counterfeits
May-07-15 04:01PM  The 4 Stocks That Lifted the Dow on Thursday at 24/7 Wall St.
01:24PM  U.S. Consumers Are Spending Again, Early Data Suggests at Bloomberg
09:49AM  Visa Analysis Shows Retail Spending Up in April Across Most Major Categories at noodls
09:26AM  Americans are reluctant to spend the money they've saved on gas, Visa survey shows at MarketWatch
09:00AM  Visa Analysis Shows Retail Spending Up in April Across Most Major Categories Business Wire
May-06-15 03:30PM  Qiwi Upgraded On Stronger Russian Ruble, Stock Rises at Investor's Business Daily
May-05-15 04:33PM  Visa Inc. to Participate in Upcoming Investor Conferences at noodls
04:05PM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
12:53PM  Stocks slip as bulls try holding market milestones at CNBC
12:22PM  Visa Continues Small Business EMV Chip Education Tour in Cincinnati Partnering with Vantiv at noodls
09:30AM  The Zacks Analyst Blog Highlights: Visa, McDonald's, SuperCom, China Southern Airlines and Aaron's - Press Releases
May-04-15 10:30PM  TVB Gives Customers Anytime, Anywhere Entertainment With CyberSource Solutions PR Newswire
03:26PM  Visa Earnings Analysis: By the Numbers
02:04PM  Visa Launches Online Toolkit to Educate Business Owners on Benefits of Chip Technology at noodls
01:55PM  Visa Launches Online Toolkit to Educate Business Owners on Benefits of Chip Technology Business Wire
May-03-15 08:13PM  10-Q for Visa, Inc. at Company Spotlight
May-01-15 12:00PM  Stocks Rebound After Data, Earnings
10:54AM  Expedia, AIG rally; LinkedIn sinks as outlook dims at MarketWatch
09:35AM  Visa Beats Q2 Earnings on Higher Revenue, Guidance Intact - Analyst Blog
09:10AM  LinkedIn sinks;Tesla's power play; Visa gets swiped
08:16AM  Sell in May and go away?;Tesla's new battery; Starbucks' mini shop
07:53AM  Early movers: NWL, MCO, VFC, CVS, LNKD & more at CNBC
07:24AM  Visa (V) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
Apr-30-15 07:42PM  Judge Orders American Express to Revise Merchant Agreements at The Wall Street Journal
07:39PM  Visa forecasts current-quarter profit below Street Reuters
06:25PM  Visa's Profit Flat Amid Higher Expenses at The Wall Street Journal
05:37PM  Visa 2Q profits fall 3 percent on strong dollar, gas sales
05:35PM  Thursday's after-hours buzz: LinkedIn, AIG & more at CNBC
05:06PM  Visa Trips on Earnings Despite Overcoming Currency Headwinds at 24/7 Wall St.
04:50PM  Visa Profit Falls on Strong Dollar as Earnings Forecast Trimmed
04:47PM  Visa Inc. Reports Fiscal Second Quarter 2015 Net Income of $1.6 billion or $0.63 per Diluted Share at noodls
04:31PM  VISA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:27PM  Visa (V) Stock Falls in After-Hours Trading Despite Earnings Beat at TheStreet
04:23PM  Visa quarterly operating revenue rises 7.8 pct Reuters
04:07PM  LinkedIn earnings: 57 cents a share vs expected EPS of 56 cents at CNBC
04:05PM  Visa Inc. Reports Fiscal Second Quarter 2015 Net Income of $1.6 billion or $0.63 per Diluted Share Business Wire
04:01PM  The 4 Stocks That Tanked the Dow on Thursday at 24/7 Wall St.
02:12PM  Trades to go as April winds down at CNBC
09:33AM  McDonalds (MCD), Autodesk (ADSK), Visa (V): WCG Managements Top Picks for Q2 at Insider Monkey
09:16AM  Payments Industry Moves to Help Simplify Chip Card Acceptance at noodls
09:00AM  Payments Industry Moves to Help Simplify Chip Card Acceptance Business Wire
08:46AM  Visa Expands Global Technology Research; Hires Senior Scientist to Lead Visa Research Labs at noodls
08:00AM  Visa Expands Global Technology Research; Hires Senior Scientist to Lead Visa Research Labs Business Wire
07:44AM  Can Visa,Tesla spark stalled market?
07:07AM  Q2 2015 Visa Inc Earnings Release - After Market Close
12:33AM  [$$] MasterCard Profit Tops Expectations, but Warns of Currency Headwinds at The Wall Street Journal
Apr-29-15 06:08PM  Visa Earnings Preview: What The Street And Crowd Expect
05:33PM  Market digs for next clue for data dependent Fed at CNBC
05:00PM  More earnings on tap
03:42PM  What to Watch in the Day Ahead - Thursday, April 30 Reuters
03:38PM  Visas Impressive Earnings History
02:20PM  5 Things to Watch in Visa's Earnings at The Wall Street Journal
01:43PM  Stocks off lows ahead of Fed statement; GDP eyed at CNBC
12:07PM  Discover Financial Increases Dividends in 1Q15
11:22AM  MasterCard Beats Q1 Earnings on Strong Volumes (Revised) - Analyst Blog
10:53AM  [$$] MasterCard Profit Tops Expectations, but Warns of Currency Headwinds at The Wall Street Journal
08:44AM  MasterCard Q1 Earnings Tops On Volume, Transactions at Investor's Business Daily
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It owns and operates VisaNet that is involved in the authorization, clearing, and settlement of payment transactions; and provision of fraud protection for account holders and assured payment for merchants. The company also offers a range of issuer processing services for participating issuers of Visa debit, prepaid, and ATM payment products. In addition, it provides electronic payment, risk management, and payment security solutions to online merchants; digital goods transactions services in online games, digital media, and social networks; and mobile financial services for mobile network operators and financial institutions in developing economies. The company offers its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHEY ELLENVICE CHAIR RISK & PUB POLICYMar 02Sale277.004,7851,325,4459,837Mar 03 06:52 PM
RICHEY ELLENVICE CHAIR RISK & PUB POLICYFeb 09Sale267.417,9662,130,18814,622Feb 11 06:13 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERFeb 02Sale255.893,438879,75044,446Feb 04 06:57 PM
Sheedy William M.EVP CORP STRAT, M&A, GRNov 11Option Exercise0.0025,4320115,997Nov 13 06:49 PM
Sheedy William M.EVP CORP STRAT, M&A, GRNov 11Sale249.1725,4326,336,89190,565Nov 13 06:49 PM
RICHEY ELLENVICE CHAIR RISK & PUB POLICYNov 05Option Exercise0.001,125012,820Nov 07 05:45 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERSep 03Option Exercise0.004,867063,897Sep 04 04:35 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERSep 03Sale215.0714,5453,128,19349,352Sep 04 04:35 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJun 16Option Exercise0.003,582066,334Jun 17 06:39 PM
LUCIO ANTONIOEVP & CHIEF BRAND OFFICERJun 16Sale210.887,3041,540,26859,030Jun 17 06:39 PM
PPG [NYSE]
PPG Industries Inc.
IndexS&P 500 P/E27.16 EPS (ttm)8.44 Insider Own0.40% Shs Outstand136.40M Perf Week-1.08%
Market Cap31.26B Forward P/E17.66 EPS next Y12.98 Insider Trans-30.17% Shs Float135.88M Perf Month1.80%
Income1.18B PEG2.54 EPS next Q3.28 Inst Own72.60% Short Float0.64% Perf Quarter-2.77%
Sales15.39B P/S2.03 EPS this Y34.10% Inst Trans-0.80% Short Ratio1.21 Perf Half Y9.46%
Book/sh37.17 P/B6.17 EPS next Y13.33% ROA6.70% Target Price256.24 Perf Year18.22%
Cash/sh8.58 P/C26.72 EPS next 5Y10.68% ROE20.60% 52W Range169.96 - 237.13 Perf YTD-0.24%
Dividend2.88 P/FCF2404.73 EPS past 5Y31.10% ROI13.60% 52W High-3.35% Beta1.29
Dividend %1.26% Quick Ratio1.10 Sales past 5Y4.60% Gross Margin43.00% 52W Low34.85% ATR3.10
Employees44400 Current Ratio1.50 Sales Q/Q0.70% Oper. Margin10.20% RSI (14)57.93 Volatility0.96% 1.40%
OptionableYes Debt/Eq0.91 EPS Q/Q34.70% Profit Margin7.60% Rel Volume0.52 Prev Close229.23
ShortableYes LT Debt/Eq0.79 EarningsApr 16 BMO Payout31.90% Avg Volume716.38K Price229.19
Recom1.90 SMA201.72% SMA501.60% SMA2006.57% Volume371,417 Change-0.02%
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Oct-09-14Initiated RBC Capital Mkts Outperform $250
Jul-01-14Reiterated Deutsche Bank Buy $220 → $235
Apr-25-14Reiterated Argus Buy $216 → $224
Apr-21-14Reiterated Deutsche Bank Buy $213 → $220
Dec-06-13Reiterated Deutsche Bank Buy $195 → $210
Jul-22-13Reiterated UBS Neutral $148 → $156
Jul-22-13Reiterated RBC Capital Mkts Outperform $160 → $176
Jul-22-13Reiterated Barclays Equal Weight $157 → $167
Feb-12-13Resumed Barclays Equal Weight $149
Jan-23-13Reiterated Argus Buy $136 → $157
Jan-04-13Reiterated UBS Neutral $118 → $136
Dec-18-12Reiterated Deutsche Bank Buy $132 → $150
Aug-08-12Reiterated UBS Neutral $98 → $111
Jun-22-12Initiated Robert W. Baird Outperform $120
Apr-20-12Reiterated UBS Neutral $90 → $98
Apr-10-12Reiterated Barclays Equal Weight $101 → $105
Feb-01-12Reiterated Barclays Capital Equal Weight $92 → $101
Nov-18-11Reiterated Barclays Capital Equal Weight $85 → $93
May-25-15 01:45PM  PPG Industries to Unveil Innovel Beverage-Can Coatings - Analyst Blog
May-21-15 02:30PM  PPG Industries Unveils Metal Coatings Color Selector Tool - Analyst Blog
May-20-15 03:08PM  GLIDDEN Paint by PPG Rolls Out THE SMARTER WAY TO WOW Campaign Business Wire
May-18-15 08:49AM  Five things to know today, and Heinz finally gets some love (after last week's snub) at bizjournals.com
May-15-15 08:09AM  These 5 Stocks Look Toxic for Your Portfolio in May at TheStreet
May-13-15 02:35PM  PPG Industries Launches Powercron AdvantEdge Electrocoat - Analyst Blog
May-12-15 03:15PM  PPG Industries' Solarban 60 on 3rd Certified 'Living' Building - Analyst Blog
01:00PM  PPG Announces Executive Appointments Business Wire
May-11-15 04:12PM  Defense attorney seeks psych exam in PPG trade secrets case
08:35AM  Five things to know today, and a bad day for Westinghouse Electric's parent company at bizjournals.com
May-08-15 11:22PM  FBI Alleges Former PPG Employee Gave Trade Secrets to Chinese Firm at The Wall Street Journal
07:00PM  Exec: The Laughing Stopped When We Became No. 1
05:24PM  PPG Agilon Performance Silica for Goodyear Tires - Analyst Blog
02:27PM  Feds: Ex-PPG employee stole trade secrets for Chinese firm
May-07-15 07:53PM  Jim Cramer's 'Mad Money' Recap: The 5 Ingredients in Today's Rally Recipe at TheStreet
07:24PM  Cramer Remix: Lightning Round history made at CNBC
07:09PM  Cramer: All the chart stars aligned for this group at CNBC
06:57PM  What the charts say about the chemical space
06:32PM  Cramer: Europe's back, baby-Perfect way to play it at CNBC
06:25PM  Cramer looks into PPG
06:00AM  Jim Cramer's Top Takeaways: Hain Celestial, PPG, Spectra Energy at TheStreet
May-06-15 08:21PM  Jim Cramer's 'Mad Money' Recap: Don't Let Janet Yellen Scare You From Stocks at TheStreet
07:17PM  Cramer Remix: How to benefit off the Fed at CNBC
May-05-15 08:14PM  New PPG online video demonstrates benefits of INTERCEPT spacer system at noodls
01:13PM  Goodyear to use AGILON performance silica by PPG to improve tire performance at noodls
01:03PM  HOMAX PRO GRADE Popcorn Ceiling Texture Helps Contractors Increase Productivity During Home Renovation Season Business Wire
08:33AM  Goodyear to Use AGILON Performance Silica by PPG to Improve Tire Performance Business Wire
May-04-15 06:24PM  PPG to debut color selector tool, e-binder app at AIA Convention 2015 at noodls
09:32AM  Apple Inc. (AAPL), Gilead Sciences (GILD) & Facebook Inc (FB): Among Top Picks of Columbus Circle Investors at Insider Monkey
May-01-15 03:55PM  PPG Industries Unveils Olympic ONE Color Changing Paint - Analyst Blog
01:04PM  PPG INDUSTRIES INC Financials
Apr-30-15 05:39PM  Corning (GLW) Earnings Analysis: By the Numbers
04:47PM  Soothing blues create optimism in the home, according to GLIDDEN paint by PPG at noodls
04:47PM  PPG Protective and Marine Coatings showcases PFP coating at OTC 2015 at noodls
04:47PM  PPG congratulates Toyota of Orlando on manufacturer recognition at noodls
Apr-29-15 08:15PM  10-Q for PPG Industries, Inc. at Company Spotlight
05:07PM  OLYMPIC brand by PPG launches ONE Color Changing Ceiling Paint at noodls
03:02PM  OLYMPIC Brand by PPG Launches ONE Color Changing Ceiling Paint Business Wire
Apr-27-15 05:32PM  PPG INDUSTRIES INC Files SEC form 10-Q, Quarterly Report
04:17PM  PPG to highlight new ENVIROCRON HTE coating at 2015 Powder Coating Show at noodls
08:30AM  Five things to know today, and how 3G Capital's founder could get big payday when Kraft-Heinz merger closes at bizjournals.com
Apr-24-15 12:24PM  PPG foundation supports Woodstock High School model airplane project at noodls
Apr-23-15 09:45AM  Bunch of PPG presenting at Wells Fargo 2015 Industrial and Construction Conference at noodls
08:41AM  Bunch of PPG Presenting at Wells Fargo 2015 Industrial and Construction Conference Business Wire
Apr-22-15 10:24PM  OLYMPIC Brand by PPG releases new ONE Stucco and Masonry Paint at noodls
04:58PM  Research and Markets: Global Caustic Soda Market Report 2015-2019 - Application Analysis: Food, Pulp & Paper, Organic Chemical, Inorganic Chemical, Alumina, Soaps & Detergents, Textiles, Water Treatment, Steel/Metallurgy, and Others Business Wire
03:02PM  OLYMPIC Brand by PPG Releases New ONE Stucco and Masonry Paint Business Wire
12:16PM  PPG reports growth in sustainable product sales, progress on sustainability goals at noodls
10:03AM  PPG Reports Growth in Sustainable Product Sales, Progress on Sustainability Goals Business Wire
Apr-21-15 07:34PM  PPG to debut SOLARBAN 90 glass at AIA National Conference and Expo at noodls
07:34PM  PPG Protective and Marine Coatings certified as RCEP education provider at noodls
10:53AM  PPG INDUSTRIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements and
09:30AM  Zacks Industry Outlook Highlights: PPG Industries, Albemarle, Air Products and Chemicals, Celanese and LyondellBasell Industries - Press Releases
Apr-20-15 04:20PM  PPG Industries' CEO Talks Progress, Performance - Analyst Blog
Apr-18-15 12:01AM  CSX Payouts Head North at Barrons.com
Apr-17-15 03:05AM  Heres what CEOs said about the economy this week
Apr-16-15 03:45PM  PPG chairman notes strategic milestones, record financials at annual meeting at noodls
03:37PM  PPG INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:25PM  PPG Industries (PPG) Stock Gains Today on Earnings Beat at TheStreet
02:24PM  PPG Results Hit by Forex at The Wall Street Journal
02:00PM  PPG Industries Inc Earnings Call scheduled for 2:00 pm ET today
01:59PM  PPG Industries' Q1 Earnings Top, Currency Hurts Sales - Analyst Blog
01:03PM  PPG Chairman Notes Strategic Milestones, Record Financials at Annual Meeting Business Wire
10:35AM  Sherwin-Williams' Q1 Earnings, Reaffirms FY15 View - Analyst Blog
09:54AM  PPG Industries (PPG) Tops Q1 Earnings, Revenues Fall Shy - Tale of the Tape
09:27AM  PPG directors increase quarterly dividend and approve 2-for-1 stock split at noodls
09:15AM  PPG Industries 1Q results mixed; OKs 2-for-1 stock split
08:58AM  Sherwin-Williams Misses Views, But Gives Rosy Outlook at Investor's Business Daily
08:38AM  PPG Industries board approves dividend hike, 2-for-1 stock split at MarketWatch
08:32AM  PPG Directors Increase Quarterly Dividend and Approve 2-for-1 Stock Split Business Wire
08:26AM  PPG reports record first quarter sales and earnings per share at noodls
08:18AM  PPG Industries beats 1Q profit forecasts
08:11AM  PPG Reports Record First Quarter Sales and Earnings Per Share Business Wire
07:07AM  Q1 2015 PPG Industries Inc Earnings Release - Before Market Open
Apr-15-15 06:15PM  Focus on companies that can reinvent themselves: Cramer
01:38PM  AQR Capital Commences Stake in LyondellBasell Industries
Apr-14-15 11:20AM  Will the Earnings Streak Continue for PPG Industries (PPG)? - Analyst Blog
08:02AM  Sherwin-Williams Eyes Big EPS Gain For First Quarter at Investor's Business Daily
Apr-13-15 06:00AM  This is the next thing that could rock stocks at CNBC
Apr-10-15 05:42PM  This is Teslas most popular car color at MarketWatch
04:42PM  This is the next thing that could rock stocks at CNBC
02:21PM  Building Trends Paint Bright Sherwin-Williams Outlook at Investor's Business Daily
Apr-09-15 02:41PM  PPG glass helps Pittsburgh building earn LIVING BUILDING CHALLENGE certification at noodls
02:41PM  PPG acquires specialty wood care and paint products manufacturer FLOOD Australia at noodls
Apr-08-15 01:12PM  OLYMPIC brand by PPG expands RESCUE IT! Resurfacer + Sealant in One line at noodls
04:28AM  PPG sponsors restoration seminar for custom car builders at noodls
04:28AM  PPG recognized as Good Enterprise Fulfilling Corporate Social Responsibility at noodls
04:28AM  PPG Platinum Distributor of the Year award presented to BAPS Auto Paints & Supply at noodls
04:28AM  PPG foundation supports Geff Grade School programs at noodls
04:28AM  PPG debuts SPECTRACRON polyester urethane mid-gloss black liquid topcoat at noodls
04:28AM  PPG Aerospace solar-control coatings use eggplant-like technology for cooler plane at noodls
Apr-07-15 10:02AM  HOMAX PRO GRADE Wall Texture Products Provide Quick, Invisible Wall Repairs For Array of Surfaces Business Wire
Apr-02-15 09:30AM  PPG Industries Wraps Up REVOCOAT Buy from AXSON Group - Analyst Blog
Apr-01-15 10:19PM  Victims' family at exec's crash sentencing: You're heartless AP
09:44PM  Family at exec's fatal crash sentencing: You're heartless AP
05:18PM  Ex-executive at fatal-crash sentencing: I wasn't suicidal
11:00AM  PPG Industries (PPG) Completes Buyout of Flood Australia - Analyst Blog
09:38AM  PPG Completes Acquisition of Automotive Specialty Materials Manufacturer REVOCOAT at noodls
08:11AM  PPG Completes Acquisition of Automotive Specialty Materials Manufacturer REVOCOAT Business Wire
Mar-31-15 12:00PM  PPG PITTSBURGH PAINTS Brand and Independent We Stand Organization Partner to Support Independent Dealers Business Wire
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. The company's Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; sealants, coatings, maintenance cleaners, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; and chemical management services. This segment also offers protective and marine coatings and finishes for the protection of metals and structures to metal fabricators and heavy duty maintenance contractors, as well as to the manufacturers of ships, bridges, and rail cars; architectural coatings used by painting and maintenance contractors, and consumers for decoration and maintenance of residential and commercial building structures; and purchased sundries to painting contractors and consumers. Its Industrial Coatings segment provides adhesives and sealants for the automotive industry, and metal pretreatments and related chemicals for industrial and automotive applications; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards applications; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The company's Glass segment produces flat glass and fiber glass for commercial and residential construction, and wind energy, energy infrastructure, transportation, and electronics industries. PPG Industries, Inc. sells its products through owned stores, home centers, paint dealers, concessionaires, other consumer retail outlets, independent distributors, and directly to customers. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHENHAGEN MARTINDirectorApr 15Option Exercise0.0063008,867Apr 17 02:36 PM
HOOPER MICHELE JDirectorApr 15Option Exercise0.0063006,255Apr 17 02:31 PM
BERGES JAMES GDirectorApr 15Option Exercise0.0063004,369Apr 17 02:12 PM
MCGARRY MICHAEL HPresident & COOFeb 26Option Exercise89.946,664599,36046,371Mar 02 04:04 PM
MCGARRY MICHAEL HPresident & COOFeb 26Sale235.606,6641,570,03639,707Mar 02 04:04 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentFeb 25Option Exercise89.9412,6641,139,00033,488Feb 27 04:03 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentFeb 25Sale236.3519,3784,579,99414,110Feb 27 04:03 PM
BUNCH CHARLES EChairman and CEOFeb 23Sale236.1720,0004,723,370380,536Feb 24 04:05 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 20Option Exercise89.9414,5271,306,55836,365Feb 24 04:02 PM
BUNCH CHARLES EChairman and CEOFeb 20Sale233.9020,0004,678,091400,536Feb 24 04:05 PM
BOST GLENN E IISr. VP & Gen. CounselFeb 20Sale233.7819,8974,651,42116,468Feb 24 04:02 PM
BUNCH CHARLES EChairman and CEOFeb 18Option Exercise89.9470,7716,365,144444,949Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 18Sale234.4270,77116,590,277374,178Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 17Option Exercise89.9470,7716,365,144444,949Feb 19 04:04 PM
BUNCH CHARLES EChairman and CEOFeb 17Sale235.4970,77116,666,094374,178Feb 19 04:04 PM
RICHENHAGEN MARTINDirectorFeb 15Option Exercise0.001,27908,237Feb 17 09:03 AM
HOOPER MICHELE JDirectorFeb 15Option Exercise0.001,27905,625Feb 17 09:00 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevJan 23Option Exercise83.908,290695,53130,984Jan 27 03:47 PM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevJan 23Sale229.198,2901,899,98522,694Jan 27 03:47 PM
BOST GLENN E IISr. VP & Gen. CounselNov 14Option Exercise75.032,975223,21419,443Nov 17 10:30 AM
BOST GLENN E IISr. VP & Gen. CounselNov 14Sale205.112,975610,20216,468Nov 17 10:30 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevAug 14Option Exercise86.579,000779,10031,694Aug 15 09:01 AM
NAVIKAS DAVID BSr. VP Strat Plan & Corp DevAug 14Sale201.139,0001,810,19222,694Aug 15 09:01 AM
BUNCH CHARLES EChairman and CEOJul 22Option Exercise88.7047,7004,230,990421,878Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 22Sale210.1147,70010,022,272374,178Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 21Option Exercise88.7047,7004,230,990421,878Jul 23 01:24 PM
BUNCH CHARLES EChairman and CEOJul 21Sale208.8147,7009,960,191374,178Jul 23 01:24 PM